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1 Abstract  
Having been neglected as a cellular remnant for nearly a century, the cilium has 
recently attracted immense interest in current research. Because of the essential roles 
played by cilia in cell sensing and signalling, the numbers of human pathologies 
associated with ciliary dysfunctions are increasing. 
Cilia are microtubule-based structures protruding from the cell surface, encapsulated 
by the unique ciliary membrane and separated from the cytoplasm by a transition 
zone. The basis for a functioning cilium is the well-coordinated, bi-directional 
transport of both ciliary building blocks and turnover products along the microtubule 
axoneme, which is carried out by large proteinaceous assemblies. These assemblies 
are termed intraflagellar transport (IFT) particles and are composed of at least 20 
different proteins, separated into two distinct sub-populations, termed IFT complex 
A and IFT complex B, which are respectively responsible for retrograde and 
anterograde transport within the cilium. The IFT complex B is composed of at least 
14 proteins, with eight of them forming a high-ionic strength stable core complex. To 
characterize these core proteins, I have reconstituted the eight-polypeptide core 
complex of Trypanosoma brucei in a heterologous bacterial expression system. 
Analysis of the oligomeric state of the recombinant assembly revealed that the 
proteins are connected in higher order structures. The reconstituted complex is 
capable of binding liposomes, but the responsible subunit(s) still needs to be 
elucidated. The purified complex can be used for further biochemical studies and 
electron microscopy analyses; for crystallographic approaches a eukaryotic 
expression system should be used to produce a more homogeneous sample. 
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2 Zusammenfassung 
In den letzten Jahrzehnten ist ein bis dahin kaum charakterisiertes Organell immer 
mehr in den Blickpunkt neuer Forschungsprojekte gerückt: das Cilium. Dieser 
Zellfortsatz spielt eine bedeutende Rolle in Signalübertragungswegen und steht in 
direktem Zusammenhang mit der Entwicklung diverser Krankheiten. Cilien sind aus 
einem Mikrotubuli-Axonem aufgebaut, welcher von der Plasmamembran umgeben 
ist, und über die Zelloberfläche hinaus wächst. Die Grundlage aller funktionierende 
Cilien ist der bidirektionale Transport der verschiedenen ciliaren Moleküle entlang 
des Axonems, der von großen Proteinkomplexen durchgeführt wird. Diese Einheiten 
werden als Intraflagellarer Transport (IFT) - Partikel bezeichnet, der in zwei 
Subpopulationen unterteilt werden kann: zum einen IFT Komplex A, der für den 
retrograden Transport verantwortlich ist und ausserdem IFT Komplex B, der 
unerlässlich für den anterograden Transport ist. IFT Komplex B besteht aus 
mindestens 14 verschiedenen Proteinen, von denen 8 auch bei hoher Ionenstärke 
miteinander verbunden bleiben und den Kern des Komplex B bilden.  Die vorliegende 
Studie beschäftigt sich mit den acht Proteinen des IFT-B Kernes aus dem Organismus 
Trypanosoma brucei. Um alle Untereinheiten gemeinsam in einem heterologen 
bakteriellem System zu exprimieren, wurde das pETDuet System verwendet. Um den 
Komplex aufreinigen zu können, wurden zwei der acht IFT-B Kern Proteine mit 
einem Affinitäts-Tag fusioniert. Der rekombinante Kern von IFT Komplex B wurde 
auf eine Chromatographie-Säule geladen, wo er unterschiedliche oligomere Einheiten 
aufweist; von Aggregaten bis hin zu dem einzelnen Komplex. Die nachfolgenden 
Versuche fokussierten sich auch die Reinigung einer homogeneren Probe. 
Biochemische Analysen zeigten, dass wenigstens eine oder mehrere Untereinheiten 
an Liposomen binden, wobei es noch ungeklärt ist, welche das sind. Der partiell 
aufgereinigte Komplex kann für biochemische Studien und 
elektronenmikroskopische Analysen verwendet werden, kristallographische Ansätze 
sollten in Zukunft mit einem eukaryotischen Expressionssystem verfolgt werden, um 
eine homogenere Probe zu erhalten. 
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3 Introduction  
3.1 Cilia 
In 1676, van Leeuwenhoek for the first time described the organelle that was, after 
the initial interest faded, going to be scientifically neglected for most of the following 
centuries and, just in recent years, re-gained immense attention: the cilium (Haimo 
and Rosenbaum, 1981; Ringo, 1967; Satir, 1995). Originally distinguished from 
eukaryotic flagellum by means of copy numbers per cell, length, and beat modes, 
both terms are now used interchangeably since both describe basically an identical 
structure (Fisch and Dupuis-Williams, 2011). It has to be mentioned though that the 
eukaryotic flagellum should not be confused with the bacterial flagellum, which 
differs not only on a structural but also on a mechanistic level with its namesake 
(Macnab, 2003). The bacterial flagellum is a rather rigid structure that rotates clock- 
or anti-clockwise in contrast to the bending or whip-like motion of the eukaryotic 
flagellum (Macnab, 2003). Moreover, while the eukaryotic flagellar axoneme is 
assembled from microtubules, dyneins, and other accessory proteins, the bacterial 
flagellum is composed of multiple units of the protein flagellin (Alberts et al., 2002; 
Macnab, 2003).  
Two examples of cilia in different organisms can be seen in Figure 1. Cilia and flagella 
have since been detected on numerous types of cells, ranging from protists to higher 
eukaryotes. Most of the initial ciliary research has been conducted in the green algae 
Chlamydomonas reinhardtii (Cr); other prominent model organisms include 
Caenorhabditis elegans (Ce), Trypanosoma brucei (Tb), Danio rerio (Dr) and Mus 
musculus (Mm).  
Due to the increasing numbers of human disorders associated with ciliary 
dysfunctions, this organelle represents a fascinating object for scientific investigation. 
The following chapter will introduce both the structural composition of the cilium 
and how the structure is maintained, and will also give an overview of some of its 
important components within. 
 18 
 
Figure 1 Scanning electron microscope images of cilia. The left panel shows a Chlamydomonas 
reinhardtii cell with two flagella. The right panel displays the multi-ciliated epithelial cells of mammalian lung 
trachea. Both images were taken at 20,000" magnification by the Dartmouth electron microscopy facility 
(http://remf.dartmouth.edu/imagesindex.html).  
 
3.2  Ciliary architecture 
The cilium is a membrane-encapsulated protrusion from the cell surface of almost all 
eukaryotic cell types. Its core structure is the ciliary axoneme, a microtubule based 
formation that extends from the basal body. As its precursor - the mother centriole, 
the basal body is composed of a ring of nine microtubule triplets. This circular 
structure is continued by the ciliary axoneme with the distinction that only two of the 
triplet microtubules further elongate. Thus a transition to doublet microtubules is 
observed (Figure 2). In the most distal part of the cilium a further decline in tubular 
number can be observed in plenty of organisms, leaving only singlet microtubules 
behind (singlet zone) (Fisch and Dupuis-Williams, 2011). No well-defined length of 
this singlet zone has been determined yet; variations in size are observed between 
different organisms as well as cell types (Fisch and Dupuis-Williams, 2011). 
 19 
 
Figure 2 Architecture of the cilium. A schematic representation of the cilium is shown. Side- and cross-
section views show the different layers from the basal body to the tip of the cilium, as well as the nine-fold 
symmetry of the microtubule ring. Motile cilia have additional features besides the central pair, such as the radial 
spokes complex that attaches to the microtubules (Ishikawa and Marshall, 2011). The figure is adapted from 
(Czarnecki and Shah, 2012). 
The region where the change from triplet to doublet microtubules takes place is 
termed the transition zone.  It is a highly complex region that is thought to represent 
a barrier between the cytoplasm and the ciliary compartment (Czarnecki and Shah, 
2012). The transition zone in some way might act as a “flagellar pore complex” 
(Rosenbaum and Witman, 2002; Silverman and Leroux, 2009) by restricting and/or 
regulating the entry of ciliary components, similar to the nuclear pore complex. 
Recent data further support the existence of a selective diffusion barrier at the 
transition zone (Kee et al., 2012; Chih et al., 2012). Common features of this section 
are the transition fibers, projecting from the microtubules to the pericilliary 
membrane (Ringo, 1967). Although the exact composition of the region is unclear, 
several studies discovered numerous proteins that localise to the transition zone and 
basal
body
transition 
zone
doublet zone 
/axoneme
immotile, 9+0
motile, 9+2
central pair
microtubule A
microtubule B
ciliary membrane
radial spokes
singlet  
zone
dynein arms
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play an important role in regulating the cilium biogenesis. For example, Craige and 
colleagues identified C. reinhardtii protein CEP290 to be part of the transition zone. 
CrCEP290 is suggested to be a key factor for the assembly of the microtubule-
membrane linkers commonly existing in this region. Aberrant levels in flagellar 
protein content have been observed upon the loss of CEP290, indicating its role in 
regulating the access to the ciliary compartment (Craige et al., 2010).  
Garcia-Gonzalo et al described a heptameric transition zone complex in M. musculus 
that is involved in controlling the content of the ciliary membrane as well as 
regulating ciliogenesis. Dysfunction of the complex results in different types of 
ciliopathies (Garcia-Gonzalo et al., 2011). 
A recent study demonstrated that members of the nuclear pore complex 
(nucleoporins) are also located at the ciliary base (Kee et al., 2012).  Furthermore, 
blocking the function of these nucleoporins restricts some proteins from entering the 
cilium (Kee et al., 2012). Thus, nucleoporins are not only located at the base of the 
cilium but also exhibit a similar function to that they have in the nuclear pore 
complex, regulating the entry of biological macromolecules into the flagellum. 
Although the ciliary membrane originates from the cellular membrane, studies have 
shown a different composition of lipid as well as polypeptide content compared to the 
plasma membrane (Pazour and Bloodgood, 2008; Emmer et al., 2010). For example, 
the flagellar membrane of T. brucei is enriched in sterols and sphingolipids (Tyler et 
al., 2009). Also, polycystin-2, a membrane protein associated with polycystic kidney 
disease (PKD), is found with elevated levels at cilia of human and mouse kidney cells. 
Interestingly, its transport into the organelle is independent of intraflagellar 
transport (IFT; part I, chapter 1.3), but probably not its recycling back into the 
cytoplasm (Pazour et al., 2002b). On the other hand, TRPV-channel proteins of C. 
elegans cilia move only in dependence of IFT (Qin et al., 2005). This indicates the 
existence of different pathways for transporting membrane proteins into the cilium. 
Nevertheless, how they work and/or are regulated is still a key question for future 
studies. 
Cilia can be separated into two sub-groups termed 9+2 and 9+0, depending on 
whether they enclose a central pair of microtubule singlets within their microtubule 
ring (9+2) or not (9+0). In general, the 9+0 cilia are immotile, whereas the 9+2 
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flagella are motile (Figure 2) and responsible for liquid flow and cellular movement. 
In addition to missing the central pair, non-motile cilia normally lack the motor 
proteins that are essential for ciliary motility (Satir and Christensen, 2007). 
Nevertheless, exceptions to the rule have been published. Studies have identified 
non-motile 9+2 (Flock and Duvall, 1965; Reese, 1965) as well as motile 9+0 
axonemes (Nonaka et al., 1998; Kramer-Zucker et al., 2005). Figure 2 shows a 
summary of the substructures found in cilia (Czarnecki and Shah, 2012). 
The non-motile 9+0 flagellum frequently occurs as a single copy on the cell surface. It 
is called the primary cilium and plays a major role in signal transduction and sensing 
the cells environment (Pazour and Witman, 2003; Berbari et al., 2009). It has to be 
mentioned that besides their mechanistic properties, motile cilia also possess sensory 
functions (Shah et al., 2009). Additionally to the central pair, radial spokes (Figure 2) 
and dynein arms are attached to the microtubule doublets of 9+2 cilia, enabling the 
bending/beating of the cilium (Satir and Christensen, 2008). Flagella missing certain 
components of the radial spokes are characterised by an inability to move normally or 
even at all (Witman et al., 1978). Recently, a cryoelectron tomography study of the 
radial spoke complex of C. reinhardtii  (composed of 23 proteins) was able to localise 
subsets of the involved proteins in the whole spoke complex and their possible 
contact with other axonemal constituents (Pigino et al., 2011), delivering further 
insight into the structural complexity of the ciliary skeleton. 
 
3.3  Centrosome and basal body 
As mentioned above, cilia emerge from the basal body, which originates from the 
mother centriole. The cilium and the basal body exhibit similar structures with the 
most prominent one being the nine-fold symmetry of the microtubules. Centrioles 
are observed as pairwise structures within the cells and have two distinct roles, (a) to 
organise the centrosomes, and (b) to nucleate the cilium as the basal body. The 
centriole is duplicated via a conserved pathway in which the existing centriole acts as 
a template for the newly formed daughter centriole. Only one of the two centrioles - 
the mother centriole - transforms into the basal body that gives rise to the cilium 
(Hoyer-Fender, 2010). On the other hand, it has been observed that centrioles can 
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also form de novo from fibrogranular assemblies when no templating centrioles exist. 
This pathway is commonly used in cells displaying multiple cilia on their surface 
(Sorokin, 1968; Brito et al., 2012).  Ciliogenesis starts with the addition of a golgi-
derived vesicle to the distal end of the centriole, followed by the formation of the 
ciliary axoneme (Sorokin, 1962). More vesicles will integrate to the initial one until a 
fusion between the centriole-vesicle and the plasma membrane takes place (Sorokin, 
1962).  Further elongation of the cilium is mediated by the integration of axonemal 
components at the tip of the flagellum by means of intraflagellar transport (part I, 
chapter 1.3). Prior to mitosis, the cilium is resorbed in order to free the basal body for 
its role as the microtubule-organising center (MTOC) during the cell cycle. Studies 
suggest that the flagella do not have to be completely resorbed for the release of the 
centriole (Parker et al., 2010). Due to this rather close relationship between the 
centrosome and the basal body, it is not surprising that some proteins fundamental 
for ciliogenesis have been identified to play important roles during the cell cycle, as 
will be described later. 
 
3.4  Intraflagellar transport 
Since no proteins are synthesised within the cilium, a mechanism for transporting 
ciliary building blocks and other molecules into and within the organelle is required. 
The process of transporting molecules to the tip as well as recycling turnover 
products is called intraflagellar transport (IFT). This bi-directional movement was 
first described two decades ago by Kozminski and colleagues (Kozminski et al., 1993) 
when they visualised an intra-ciliary motility in Chlamydomonas unrelated to 
flagellar kinetics by using differential interference-contrast microscopy. This marked 
the starting point for a new direction in ciliary research, focusing on unravelling the 
underlying mechanistic of IFT as well as its association with signal transduction 
processes and subsequently diverse ciliopathies.  
IFT is carried out by an intricate machinery composed of a vast number of different 
proteins that possess distinguished roles in the whole process. In general, IFT is a bi-
directional movement of ciliary molecules along the axoneme. The main component 
is the IFT particle, a multi-subunit polypeptide assembly (Figure 3). 
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Figure 3 Intraflagellar transport. A simplified representation of IFT within the flagellum. Trains of IFT 
particles are moving with different velocities along the ciliary axoneme with the coordinated help of the respective 
motor proteins. At the tip, a remodelling of the particles and cargo-exchange take place in order to recycle the 
turnover products back to the ciliary compartment. 
Members of the IFT complex were initially identified by Piperno and Mead over a 
decade ago (Piperno and Mead, 1997). They analysed flagellar extracts of C. 
reinhardtii and discovered a protein complex composed of at least 13 different 
subunits. Shortly afterwards, Cole and colleagues (Cole et al., 1998) also reported the 
purification of the particle from Chlamydomonas and the detection of 15 different 
subunits within. They named the different polypeptides regarding their apparent 
molecular weights on an SDS-PAGE gel as p172, p144, p140, p139, p122, p88, p81, 
p80, p74, p72, p57/55, p52, p46, p27, and p20 (the p was later replaced by IFT, 
which until now is the commonly used nomenclature for IFT particle components). 
Additionally, they managed to further distinguish two stable sub-populations of the 
complex, termed complex A (IFT-A; part I, chapter 3.4.1) and complex B (IFT-B; part 
I, chapter 3.4.2) (Cole et al., 1998).  
To date, IFT complex A has been confirmed to consist of IFT144, IFT140, IFT139 and 
IFT122 plus the later identified IFT121 (Blacque et al., 2006) and IFT43 (Piperno et 
al., 1998). IFT-B consists of IFT172, IFT88, IFT81, IFT80, IFT74/72, IFT57/55, 
IFT52 IFT46, IFT27, IFT20 and the more recently discovered subunits IFT25 (Follit 
et al., 2009; Lechtreck et al., 2009), IFT22 (Schafer et al., 2006), putative IFT54/Dyf-
11 (Li et al., 2008; Omori et al., 2008; Follit et al., 2009), and IFT70 (Fan et al., 
anterograde
retrograde
kinesin-2 cytoplasmic dynein
cargo
cargo
IFT particle
 cilium
transition
zone
basal
body axonemeaxoneme
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2010). These novel subunits have been identified in various organisms, ranging from 
Chlamydomonas reinhardtii over Caenorhabditis elegans to Mus musculus. 
Table 1 Overview of the various names of IFT components in different organisms. Adapted from 
(Ishikawa and Marshall, 2011; Follit et al., 2009) 
IFT 
component 
Chlamydomonas 
reinhardtii (Cr) 
Caenorhabditis 
elegans (Ce) 
Homo 
sapiens 
Other 
IFT complex A IFT144 DYF-2 WDR19  
 IFT140 CHE-11 IFT140  
 
IFT139 ZK328.7 THM1, 
TTC21B 
 
 
IFT122 DAF-10 IFT122, 
WDR10 
 
 IFT121 IFTA-1 WDR35  
 
IFT43 - IFT43, 
C14orf179 
 
 
IFT 
component 
Chlamydomonas 
reinhardtii (Cr) 
Caenorhabditis 
elegans (Ce) 
Homo 
sapiens 
Other 
IFT complex B IFT172 OSM-1 IFT172  
 
IFT88 OSM-5 IFT88 
Tg737, 
Polaris 
 IFT81 IFT-81 IFT81  
 
IFT80 CHE-2 IFT80, 
WDR56 
 
 IFT74 IFT72 IFT-74 IFT74, IFT72  
 
IFT70 DYF-1 TTC30A, 
TTC30B 
Fleer 
 IFT57 CHE-13 IFT57  
 
IFT54, FAP116 DYF-11 IFT54, 
TRAF3IP1 
Elipsa 
 IFT52 OSM-6 IFT52, NGD5  
 
IFT46, FAP32 DYF-6 IFT46, 
C11orf60 
 
 IFT27, FAP156 - IFT27, RABL4  
 IFT25, FAP232 - IFT25, HSPB11  
 IFT22, FAP9 IFTA-2 RABL5  
 IFT20 Y110A7A.20 IFT20  
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Table 1 shows an overview of the naming conventions in different organisms. Since 
most of the groundbreaking work on IFT has been conducted in Chlamydomonas, I 
will by default refer to their nomenclature for IFT components.  
Most of the proteins involved in IFT have been identified as conserved among ciliated 
organisms (for complex B see (Fan et al., 2010)). Outside the flagellar compartment, 
members of IFT particle are predominantly localised at the basal body of the cilium 
(Qin et al., 2004).  Interestingly, IFT complexes A and B localise at different positions 
around the basal body (Hou et al., 2007), indicating that they are not necessarily in 
physical contact outside the flagellum. 
Although both IFT complexes travel together from the basal body to the tip and vice 
versa, different roles have been established for them, with IFT-B mainly responsible 
for the anterograde transport and IFT-A essential for a functioning retrograde 
transport. Nevertheless, some data suggests that this classic view might oversimplify 
the real situation; rather individual subunits of both complexes are linked to the 
motor proteins or cargo (Keady et al., 2012).  To enable movement along the 
axoneme, microtubular motor proteins are needed. Studies have identified the 
anterograde motor to be heterotrimeric kinesin-II (Kozminski et al., 1995; Cole et al., 
1998), and the retrograde movement to be mediated by cytoplasmic dynein 1b 
(DHC1b) (Pazour et al., 1999). Interestingly, whereas in Chlamydomonas 
heterotrimeric kinesin-II alone is sufficient for ciliogenesis, other organisms possess 
a second homodimeric kinesin, such as OSM-3 in C. elegans (Signor et al., 1999). 
Closer examination of the particle movement of the anterograde and retrograde 
transport revealed a difference in the travel velocities of both motilities. While the 
anterograde transport is moving with approximately 2 µm/sec, the retrograde 
transport advances with ~3 µm/sec (Cole and Snell, 2009). In Chlamydomonas, 
depletion of kinesin-II results in the interruption of IFT and consequently flagellar 
resorption (Kozminski et al., 1995), whereas cells harboring a deletion mutant of the 
DHC1b gene exhibit short flagella with bulgy tips (Pazour et al., 1999). Aside from 
these effects on ciliary integrity, other phenotypes can be observed upon disruptions 
in IFT motors and particles and will be explained in later (part I, chapter 3.5).  
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Figure 4 Domain arrangements of the IFT complexes. Different protein-protein interaction motifs found 
in C. reinhardtii IFT particle components. Adapted from Cole (Cole, 2003) and (Behal et al., 2012). 
Analysis of conserved domains within the IFT particles showed that most of the 
subunits have multiple putative protein-protein interaction motifs such as the WD-
40 repeat, the tetratricopeptide repeat (TPR) and coiled-coil domains (Figure 4).  
Additionally, degenerate TPR-like repeats (WAA) were identified in most of complex 
A proteins, which were initially termed degenerative repeats (Cole, 2003; Behal et al., 
2012). Interestingly, four subunits of the IFT complex A and IFT172 of the complex B 
share a rather similar domain organisation. Furthermore, IFT27 and IFT22 of 
complex B both contain a small GTPase domain (Qin et al., 2007; Schafer et al., 
2006). 
To date, the most detailed ultra-structural examination of the IFT particle in 
Chlamydomonas is presented in the work of Pigino and colleagues (Pigino et al., 
2009). By means of transmission electron microscopy and electron-tomography, they 
observed trains of IFT particles between the flagellar membrane and the axoneme, 
with linkages to both the membrane and the axoneme. A closer look at these trains 
revealed two different types: short, thick trains with a periodicity of 16 nm and long, 
thin trains with 40 nm periodicity (Pigino et al., 2009). However, due to resolution 
limits, no individual subunits could be localised within the observed structures, 
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making it still a subject of further investigation. In order to unravel the intricate 
network underlying intraflagellar transport and its regulation, functional and 
structural studies of each single component are of immense interest.  
3.4.1 IFT complex A 
As described above, the IFT complex A consists of six different subunits. Except for 
IFT43, all other subunits of the IFT-A are rather large polypeptides, with molecular 
weights of higher than 120 kDa (Taschner et al., 2011). Due to this, less advances in 
studying these proteins in a recombinant system have been made compared to the 
IFT complex B (Behal et al., 2012). 
IFT144, IFT140 and IFT122 are capable of assembling into a stable sub-complex in 
the absence of IFT139 and IFT121 (Mukhopadhyay et al., 2010; Behal et al., 2012). 
Further analyses suggest that IFT121 is required for the integration of IFT139 and 
IFT43 into the complex (Behal et al., 2012), and IFT121 in turn requires IFT140 for 
proper association with the IFT machinery (Blacque et al., 2006). IFT43, the smallest 
and least conserved member of the IFT complex A, directly interacts with the C-
terminal part of IFT121 (Behal et al., 2012). Interestingly, in contrast to flagellar 
extracts, analysis of Chlamydomonas whole cell or cell body extracts indicates that 
only a subset of the IFT43 population is associated with the other subunits of IFT-A 
(Behal et al., 2012).  
Deficiencies in IFT-A complex proteins – similar to mutations affecting the 
retrograde motor - result in malformed and malfunctioning (Blacque et al., 2006), 
short or even absent cilia (Behal et al., 2012). Common for most of these IFT-A 
mutants are the bulges along the formed cilia that are in general enriched in IFT-B 
proteins (Piperno et al., 1998; Iomini et al., 2009) (also reviewed in (Ishikawa and 
Marshall, 2011; Taschner et al., 2011)). 
3.4.2 IFT complex B 
Current data show that the IFT complex B is composed of at least 15 different 
subunits. It has been demonstrated that under increasing ionic strengths, some 
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proteins dissociate from the complex (Lucker et al., 2005). Thus, a sub-classification 
of IFT-B into a salt-stable IFT-B core complex plus weakly associated proteins 
(Figure 5) has been made. The salt-stable core of IFT-B contains nine different 
subunits, namely IFT88, IFT81, IFT74, IFT70, IFT52, IFT46, IFT27, IFT25 and 
IFT22.  
 
Figure 5 Composition and assembly of the IFT complex B. Nine IFT-B proteins are able to form a core-
complex even under the ionic strength of 300 mM NaCl (Lucker et al., 2005). Proteins in grey easily dissociate 
from the complex B under high-salt conditions. Chemical cross-linking, in vivo binding assays and yeast-two-
hybrid studies have been conducted to identify contacts between the core members. Adapted from (Lucker et al., 
2010) and (Taschner et al., 2011). 
Depletion of certain members of IFT-B results in small, stumpy or even absent 
flagella (Brazelton et al., 2001; Haycraft et al., 2001), (further reviewed in (Ishikawa 
and Marshall, 2011; Taschner et al., 2011)) due to the fact that the required building 
blocks cannot be transported into the cilium. This phenotype is similar to mutations 
affecting the anterograde motor kinesin-2, as mentioned earlier. 
The largest subunit of the core complex is IFT88, which has been shown to contain 
several TPR repeats (Pazour et al., 2000), (Figure 4). CrIFT88 is homologous to 
mouse and human Tg737 (Table 1), a protein associated with polycystic kidney 
disease, (Pazour et al., 2000) and C. elegans OSM-5 (Haycraft et al., 2001; Qin et al., 
2001). IFT88 is essential for the formation of cilia both in Chlamydomonas (Pazour 
et al., 2000) and in vertebrates (Pazour et al., 2002a). In C. elegans, mutations in 
OSM-5 lead to significantly shorter cilia in chemosensory neurons (Haycraft et al., 
2001). Different studies established a role of IFT88 outside ciliogenesis in the cell 
IFT172
IFT88
IFT52
IFT46
IFT74/72
IFT74/72
IFT81
IFT81
IFT22
IFT25
IFT80
IFT57/55
IFT20
IFT172
IFT80IFT57/55
IFT20
IFT complex B
core
IFT70
IFT54
IFT54IFT27
 29 
cycle. In mammalian cells, centriole-associated IFT88 controls the G1-S phase 
transition (Robert et al., 2007) and is involved in maintaining the correct spindle 
orientation during mitosis (Delaval et al., 2011). 
IFT74 and IFT72 are two isoforms of the same gene (Qin et al., 2004) and are often 
referred to as IFT74/72. IFT81 and IFT74 are both composed of a long coiled-coil 
region. Cross-linking experiments followed by yeast-two-hybrid (Y2H) studies of C. 
reinhardtii constructs demonstrated that both proteins interact via their coiled-coil 
domains (Lucker et al., 2005). Furthermore, IFT81 is able to homodimerise in the 
Y2H studies, as opposed to IFT74, thus suggesting that the polypeptides form a 
hetero-tetramer composed of each two copies IFT81 and IFT74 (Lucker et al., 2005). 
Studies in C. elegans revealed that mutations in the IFT81 and IFT74 genes result in 
chemosensory deficiencies but lead to less ciliogenetic defects than other IFT-B 
mutants (Kobayashi et al., 2007). 
The most recent addition to the IFT complex B was IFT70, which represents one of 
the most conserved subunits of the complex (Fan et al., 2010). Initially identified in 
C. elegans as Dyf-1, IFT70 was shown to contain several TPR and prenyltransferase 
motifs; previous studies suggested that it mediates the interaction between the motor 
subunit OSM-3 and the IFT-particle (Ou et al., 2005). However, no direct interaction 
between IFT70 and OSM-3 could be detected, indicating an indirect link between the 
two (Ou et al., 2005). Chlamydomonas cells depleted of IFT70 show a decrease in 
their flagellar length as well as in the expression levels of other IFT-B components 
(Fan et al., 2010), whereas Tetrahymena termophila IFT70 mutants are 
characterised by de-stabilised, short axonemes (Dave et al., 2009). 
Similarly to IFT88, deletion of IFT52 has severe effects on ciliogenesis. 
Chlamydomonas deficient in IFT52 are not able to assemble cilia (Brazelton et al., 
2001). By means of immunoelectron microscopy it was established that CrIFT52 
localises to the basal body in addition to the transitional fibers close to the membrane 
(Deane et al., 2001). It is suggested that these fibers serve as a docking point for the 
IFT particles (Deane et al., 2001), before they enter the ciliary compartment. 
IFT46 is highly conserved among ciliated organisms, and Chlamydomonas null-
mutants are not able to assemble full-length, motile flagella, but only short, immotile 
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ones (Hou et al., 2007). Interestingly, comparing the axonemes of wild-type and 
ift46-mutant flagella revealed an absence of dynein arms within the axoneme, 
although normal levels of it are observed in the cell lysate (Hou et al., 2007). It was 
shown that IFT46 is crucial for the transport of the outer dynein into the flagellum 
(Hou et al., 2007), which it does with the help of another protein, ODA16 (Ahmed et 
al., 2008). As can be observed for other IFT-B proteins, deletion of IFT46 reduces the 
levels of other complex members, with the notable exception of IFT172 (Hou et al., 
2007). 
A detailed study by Qin and colleagues (Qin et al., 2007) demonstrates that CrIFT27 
is a Rab-like small GTPase, with no homologs in either C. elegans or Drosophila. Its 
association with the IFT complex B is independent of its GTP/GDP bound state (Qin 
et al., 2007). Interestingly, partial knockdown of IFT27 results in failing cell division 
and elongated cell cycle, whereas a complete knockdown is lethal (Qin et al., 2007). 
This indicates that IFT27, like IFT88, plays an important role outside the 
intraflagellar transport. 
One of the more recently identified member of the complex B-core is IFT25, which 
was identified both in C. reinhardtii (Lechtreck et al., 2009; Wang et al., 2009) and 
in M. musculus (Follit et al., 2009). As for IFT27, no homologs in C. elegans and D. 
melanogaster were detected for IFT25 (Lechtreck et al., 2009). Wang et al (Wang et 
al., 2009) identified IFT25 as a phosphoprotein, a modification shown to be 
important for its integration into IFT-B. IFT25 is not crucial for ciliary assembly but 
rather for functioning hedgehog signaling (Keady et al., 2012). Immunofluorescence 
studies reveal that IFT25 localises to the basal body as well as to areas around the 
transition zone (Wang et al., 2009). In the latter region, it overlaps with IFT27 
distribution, which goes in line with pull-down studies verifying a direct interaction 
between the two proteins (Wang et al., 2009). Notably, in the cytoplasm but not in 
the flagellum, fractions of IFT25 and IFT27 can be found as a separate entity from the 
IFT complex B (Wang et al., 2009). The crystal structure of the recombinant 
CrIFT27-IFT25 complex was recently published (Bhogaraju et al., 2011), showing an 
elongated shape with the interface mostly between the C-terminus of IFT27 and two 
loop regions of IFT25.   
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Besides IFT27, IFT22 is the second Rab-like protein of the IFT complex B. 
Interestingly it is indispensable for flagella formation in T. brucei (Adhiambo et al., 
2009) but not in C. elegans (Schafer et al., 2006). A recent study by Silva and 
colleagues (Silva et al., 2011) analysed the role of IFT22 in C. reinhardtii in more 
details. Intriguingly, although RNAi depletion of IFT22 resulted in a decrease (with 
varying extent) of the cellular pools of both IFT-A and –B proteins, an increase in 
flagellar amounts of IFT particle polypeptides was observed (Silva et al., 2011). Thus 
it was hypothesised that IFT22 is a key player in regulating the number of IFT 
particles within the cilium, hence the quantity of material transported into the 
flagellum. Remarkably, both Rab-like proteins, IFT22 and IFT27, have been found to 
lack the lipid modifications that are common for most Rab-like proteins (Qin et al., 
2007; Silva et al., 2011). 
Aside from the 9 core-components, the IFT complex B contains the herein mentioned 
peripheral subunits IFT172, IFT80, IFT57, IFT54 and IFT20. Previous studies in 
Chlamydomonas suggest that IFT172 collaborates with EB1 (microtubule end 
binding protein 1) to facilitate the reversal of the IFT particles at the flagellar tip 
(Pedersen et al., 2005).  
Studies in mouse show that expression of IFT80 at hypomorphic levels is embryonic 
lethal although no significant ciliary degenerations but rather hedgehog signaling 
defects are observed, suggesting that low levels of the protein are sufficient to 
maintain the cilium but not to continue its signaling functionality (Rix et al., 2011). 
Upon knockdown of IFT80 in D. rerio, defects of photoreceptors (Hudak et al., 2010) 
or formation of kidney cysts (Beales et al., 2007) can be observed.  
IFT57 is associated with less severe ciliogenetic defects than other IFT-B 
components; zebrafish depleted in IFT57 are still able to assemble cilia, although they 
are shorter than their wild-type counterparts (Krock and Perkins, 2008).  
Another IFT complex B member - IFT54, also known as elipsa in Danio rerio or DYF-
11 in C. elegans, contains two coiled-coil regions (Omori et al., 2008). In C. elegans, 
the C-terminal coiled-coil region was identified to be essential, whereas the N-
terminal domain was negligible for IFT54 function in cilia (Kunitomo and Iino, 
2008). Yeast two-hybrid studies indicate IFT20 and rabaptin 5, a polypeptide 
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involved in endocytic vesicle fusion, as potential binding partners of DrIFT54 (Omori 
et al., 2008). Further tandem affinity purifications using DrIFT54 as bait identified 
IFT20, IFT57, IFT80, IFT81, IFT172 and Qilin as its binding partners (Omori et al., 
2008).  
IFT20 is the smallest member of the IFT complex B and has been established to be 
unique among IFT-B members due to its additional localisation to the Golgi complex 
in mammalian systems (Follit et al., 2006). Interestingly, in T-lymphocytes, which 
are non-ciliated cells, IFT20 is expressed and localises to the Golgi, the MTOC and 
the immune synapse (Finetti et al., 2009).  
Yeast-two hybrid and pull-down studies identified MmIFT20 to bind to IFT57 (Baker 
et al., 2003; Follit et al., 2006) and kinesin-2 (Baker et al., 2003). IFT particles 
deficient in DrIFT57 do not contain IFT20 but are still able to bind to kinesin-2 
subunit (Krock and Perkins, 2008), suggesting a linkage between the motor and the 
IFT particle independent of IFT20. Further studies established MmIFT20 to be 
essential for transporting the membrane protein polycystin-2 into the ciliary 
membrane (Follit et al., 2006).  
Accordingly, Follit and colleagues (Follit et al., 2009) proposed a model in which 
IFT20 together with its Golgi-binding partner GMAP210 (Follit et al., 2008) localises 
to the Golgi network to sort the vesicles destined for the flagellar compartment. 
IFT20 associates with these vesicles and transports them to the ciliary base, where its 
interaction with IFT54 and subsequently the remaining IFT complex B takes place. 
Until now, extensive studies have been conducted to identify the binding 
partners/regions within the IFT complex B in order to understand how the complex 
is assembled and to define possible regulatory mechanisms of the assembly. For the 
core complex, following binding partners and/or sub-complexes have been 
established. As described previously, IFT74 and IFT81 are known to interact and, 
more precisely, they are thought to form a hetero-tetramer (Lucker et al., 2005). 
Chemical cross-linking experiments identified associations between IFT52 and IFT88 
as well as between IFT81 and IFT27 (Lucker et al., 2010). Tandem affinity 
chromatography studies showed that even in the absence of other IFT-B core 
components, IFT52, IFT46 and IFT88 are capable of forming a sub-core complex 
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(Lucker et al., 2010). Pull-down experiments demonstrated that CrIFT46 and 
CrIFT70 are capable of forming a dimer (Fan et al., 2010). As already mentioned, 
direct interaction of CrIFT27 and CrIFT25 has been shown via in vitro binding assays 
(Wang et al., 2009) and co-crystallisation (Bhogaraju et al., 2011). Taken the previous 
results together, it is likely that the IFT-B core assembles via 3 sub-core complexes, 
namely the tetrameric IFT81-74, the trimeric IFT88-52-46, and the dimeric IFT27-
25. The order of their recruitment to built-up the final core complex still awaits 
further studies, so as when and how the associated subunits come into play. It was 
shown that the IFT-B is pre-assembled prior to entering the ciliary compartment 
(Wang et al., 2009). However, it remains unknown to which subunit IFT22 binds. 
Pull-down studies with the peripheral subunit MmIFT20 identified IFT52, IFT57 and 
IFT88 as its binding partners (Follit et al., 2006). 
Taken together all these data on the individual IFT-B subunits, it can be concluded 
that in most cases removal of any single component has severe effects on ciliogenesis 
by disrupting the integrity of the whole transport particle. Probably due to the close 
relationship between the basal body and centrosomes, some of the IFT proteins play 
an additional role during the cell cycle, even in non-ciliated organisms. Increasing 
evidence of a role of IFT and its constituents outside the classical ciliary compartment 
(Finetti et al., 2009; Baldari and Rosenbaum, 2009; Sedmak and Wolfrum, 2010) 
and the intimate relationship with signal transduction cascades like the hedgehog 
and the Wnt signaling pathways (reviewed in (Gerdes et al., 2009; May-Simera and 
Kelley, 2012)) emphasises the immense importance of the cilium. 
3.4.3 IFT and Chaperones 
Chaperone proteins play a critical role in the folding of cellular proteins or 
degradation of denatured proteins if refolding attempts fail (reviewed in (Hartl et al., 
2011)). Hsp70 chaperones represent a well-conserved class of chaperones (Hartl and 
Hayer-Hartl, 2002) and previous studies suggest a stabilising role of the Hsp70 
proteins on cytoplasmic microtubules (Silflow et al., 2011). Interestingly, some 
Hsp70s were first identified as microtubule-associated proteins (MAPs) before their 
function as chaperones were established (Liang and MacRae, 1997). Aside from 
stress-induced Hsp70 homologs, higher eukaryotes also contain constitutively 
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expressed Hsp70, termed Hsc70 (Hartl et al., 2011). In Chlamydomonas, Hsp70 can 
be found – aside from the cytosol – in the flagellum, concentrated at the flagellar tip; 
additionally it co-localises with the anterograde motor kinesin-2 (Shapiro et al., 
2005). Interactions between Hsc70 or DnaJ with IFT components such as IFT88 
have been published (Bhowmick et al., 2009). Initial investigations suggested Hsp70 
to be part of the IFT particle (Piperno and Mead, 1997), but subsequent experiments 
did not come to the same conclusion (Cole et al., 1998). Overall, the specific role of 
chaperones/Hsp70 within the flagellum and their connection with intraflagellar 
transport is still nebulous and remains a topic for future research. 
 
3.5  Ciliopathies 
One of the main reasons that research started to regain its interest in cilia and flagella 
was the occurrence of human pathologies connected with defects in ciliogenesis and 
its associated molecules. The diverse ciliary disorders are collectively described as 
“ciliopathies”.  Prominent ciliopathies include primary cilia dyskinesia (PCD), 
polycystic kidney disease (PKD, (Pazour et al., 2000; Yoder et al., 2002)), Meckel-
Gruber syndrome (MKS, (Dawe et al., 2007)), nephronophthisis (NPHP, (Otto et al., 
2003)), Joubert syndrome (JS, (Parisi et al., 2007)), and Bardet-Biedl syndrome 
(BBS, (Kulaga et al., 2004; Mykytyn et al., 2004)). These disorders have been traced 
to cilia either losing their motile function (Afzelius, 1976) or incapable of continuing 
signal transduction. Various mutations directly involved in the onset of ciliopathies in 
human proteins have now been identified, (for reviews see (Badano et al., 2006; Oh 
and Katsanis, 2012)). A mutation of IFT80 in human patients correlates with the 
development of Jeune asphyxiating thoracic dystrophy (JATD) (Beales et al., 2007). 
Interestingly, although accumulating data suggest that dysfunction of most IFT-B 
proteins causes strong defects in ciliogenesis, there are not a lot of IFT-B gene 
mutations directly linked to human ciliopathies. A recent publication by Keady and 
colleagues (Keady et al., 2012) suggests that this could be due to prenatal lethality 
upon loss of cilia. Thus, most of these mutations are hypothesised to lead to 
miscarriage rather than the development of postnatal ciliopathies.  
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4 Aim 
Intraflagellar transport is vital for a functioning cilium, as can be seen from the 
diverse set of pathologies associated with components of this intracellular movement. 
The importance of the IFT complex B can be recognised by the fact that abolishing 
single subunits is in most cases detrimental for the functionality of the whole 
transport. To date, protein crystal structures have only been published for two small 
subunits of the IFT complex B. Low resolution electron tomography pictures have 
given an idea about the rough architecture of the complete IFT particle, but very little 
is known about the intricate machinery at the structural level.  
To shed light on the complex network and elaborate interactions within a part of the 
IFT machinery, I will try to reconstitute the IFT complex B core from T. brucei. The 
eight IFT proteins (IFT88, IFT81, IFT74, IFT52, IFT46, IFT27, IFT25 and IFT22) will 
be co-expressed with the final goal being to obtain pure sample of the protein 
complex and to characterise its assembly by various biophysical techniques and, if 
possible, to co-crystallise this recombinant IFT-B core complex. Additionally, various 
sub-core complexes such as the IFT74/IFT81 heterotetramer will be examined 
separately. Furthermore, I will also try to structurally investigate the peripheral 
subunit IFT20 that has been implicated to be important in sorting the vesicles 
destined for the cilium. Accompanying biochemical studies will provide further 
insights into the functionality of the complex. 
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5 Materials and Methods 
5.1 Cloning 
For all DNA purification and clean-up steps different commercial kits from Qiagen 
were used according to the respective manuals (QIAprep Spin Miniprep kit, QIAquick 
PCR purification, QIAquick gel extraction). All centrifugation steps were carried out 
at room temperature using a tabletop centrifuge 5424 (Eppendorf) at 13,000 rmp 
(15,871 x g). DNA concentrations were measured on a NanoDrop spectrophotometer 
ND-1000 (PeQlab). E. coli strain DH5" was used to amplify all used commercial 
vectors as well as our generated plasmids. Standard protocols for transformation into 
chemically competent cells were used.  DNA sequencing was exclusively done by LGC 
Genomics (Germany).  
The full-length ORF of the eight different IFT complex B subunits were PCR 
amplified using T. brucei cDNA as template (gift from the Warren lab, MFPL, 
Vienna) and Phusion polymerase (NEB Biolabs). 
Table 2 Constructs of IFT complex B.   
Protein Restriction sites (protein) Vector MCS Affinity Tag 
IFT46 NcoI/BamHI 1 C-terminal 6x His 
IFT52 NdeI/BamHI 
petDuet/AmpR 
2 - 
     
IFT74 NcoI/BglII 1 - 
IFT81 NdeI/BamHI 
pCDF/SmR 
2 N-terminal 6xHis 
     
IFT27 NcoI/BamHI 1 - 
IFT22 NdeI/XhoI 
pCOLA/KanR 
2 - 
     
IFT88  1 - 
IFT25 NdeI/BglII 
pACYC/CamR 
2 - 
     
Hsp70 NdeI/BamHI KiM2a/AmpR - N-terminal MBP 
IFT20 NcoI/BamHI HM15b/ AmpR - N-terminal 6xHis 
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The Duet Vector System (Novagen) was chosen to enable co-expression of all 
different subunits.  Each vector carries two multiple cloning sites (MCS). For all 
constructs, MCS1 was cut using NcoI and BamHI and MCS2 using NdeI and BglII. 
Additionally, homemade vectors with a maltose binding protein (MBP) (KiM2a) or 
6"His affinity tag (HM15b) were used. Table 2 summarises the generated constructs 
of the IFT complex B core and Hsp70 and IFT20. 
DNA sequencing result of the IFT46 construct showed an N-terminal mutation 
(M45I). This mutation was present in all IFT46 clones, which is likely pre-existing 
substitution in the cDNA used for amplification. We have observed such discrepancy 
from the deposited gene data when cloning other T. brucei genes and believe it is due 
to the difference between the two different forms of the parasite, i.e. procyclic and 
bloodstream forms. The mutation lies in a region predicted to be unstructured and 
does not change the charge of the protein. 
During initial cloning of IFT27 a mutation of the first amino acid from M1 to H was 
overlooked, resulting in no expression of this construct. To re-establish the sequence, 
the quickchange mutagenesis kit (Stratagene) was used to change the incorrect amino 
acid back to methionine. IFT22 was cloned into the second MCS of the precloned 
IFT27-pCOLA using the In-Fusion protocol (Clontech).  
Hsp70 was cloned into a homemade vector KiM2a that provides an N-terminal MBP 
tag. Sequence analysis showed an insertion of T after nucleotide No. 1895, leading to 
an earlier stop codon. The translated protein has a length of only 661 amino acids 
(aa) instead of 690 aa. This insertion was present in all constructs sent for 
sequencing, independent of the used genomic DNA. Interestingly, analysis of Hsp70 
within other Trypanosoma species showed that the homolog from T. brucei 
gambiense DAL972 has this T-insertion occurring naturally. As explained above, this 
could be due to the two different forms of the parasite. It could be possible that the 
published sequence of T. brucei Hsp70 is not correct.  
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5.2 Expression & Purification 
For the expression of recombinant proteins, E. coli strain BL21 (DE3) was used. In 
addition, E. coli strain EN2 (gift from Nadia Benaroudj, Institute Pasteur) was used, 
which is a DnaK deletion strain. EN2 cells are kanamycin resistant and need to be 
grown at # 30°C.  
Given the difficulties in cotransforming all four vectors at once, I used a two-step 
transformation strategy. In the first step, two of the vectors (either petDuet and pCDF 
or pACYC and pCOLA) were co-transformed into E. coli BL21 (DE3). In the second 
step, chemical competent cells were prepared from the colonies with two plasmids 
and used for the co-transformation of the remaining two plasmids, pACYC/pCOLA or 
petDUET/pCDF, respectively. As suggested by the Novagen protocol, the antibiotic 
concentration was halved when expressing all four plasmids together.  
To co-express the core complex with Hsp70 the following strategy was used: IFT46-
IFT52 (petDuet) and IFT74-IFT81 (pCDF) were co-transformed, as were IFT88-
IFT25 (pACYC), IFT27-IFT22 (pCOLA) and Hsp70 (KiM2a). Upon harvesting both 
cell-pellets were pooled for subsequent purification. 
All expressions were carried out at low temperature (16-18°C) to increase the amount 
of soluble proteins. In short, cells were grown to an optical density at 600 nm (OD600) 
of 0.5-0.8 at 37°C. Prior to shifting to 16°C or 18°C, the cultures were incubated on 
ice for about 10 minutes (‘cold shock’). 45-60 minutes after transferring the cultures 
to the low temperature protein expression was induced with 0.5 mM IPTG. Cells were 
harvested 16-20 hours post-induction with a JLA 8.1000 rotor on an Avanti J-26 XP 
centrifuge (Beckman Coulter). 
Pelleted cells were resuspended in lysis buffer (20 mM Tris-HCl pH 8.0, 100-300 
mM NaCl, 5% glycerol, 20 mM imidazole, 1 mM PMSF, 2 $g/ml DNAse I) and broken 
using the Emulsiflex-C3 Homogenizer (Avestin). Cell lysate was cleared by 
centrifugation at 16000 rpm (30600 rcf) for 25 minutes using a Sorvall RC5C 
centrifuge (SS34 or F21S -8x50y rotor) with additional filtration of the supernatant 
through a 0.45 µm membrane (Roth). Metal affinity chromatography was used as the 
first purification step, capturing the His-tagged subunits of the complex. This was 
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done either with a gravity column or a HisTrap chelating HP column (GE healthcare) 
on an Äkta purifier (GE healthcare). In case of gravity purification, either high 
performance nickel-sepharose (GE healthcare) or perfect pro nickel-NTA-agarose (5-
prime) was used. 0.1 M solutions of NiCl2, Zn(CH3COO)2, CuSO4 or Co(CH3COO)2 
were used for charging the affinity media. Alternatively, MBP-tagged proteins were 
purified using amylose resin (New England Biolabs) in our regular lysis buffer with 
pH adjusted to 7.5.  
Bound protein was eluted by an increasing imidazole gradient. In some cases, prior to 
eluting the bound complex, an extra wash step was added to remove possibly bound 
liposomes from the proteins. In such cases, either 1% (v/v) Triton X-100 (Sigma) or 
30 mM n-octyl-b-D-glucoside (b-OG, Glycon biochemicals) was added to the lysis 
buffer for wash.  
To capture the FLAG-tagged IFT81, Anti-FLAG M2 affinity gel (Sigma) was used in 
buffer containing 20 mM Tris-HCl pH 8.0, 300 mM NaCl, and 5% glycerol. To elute 
bound proteins, either FLAG-peptide (Sigma) or 0.1 M glycine pH 3.5 were used 
according to the manufacture’s manual. 
For ion-exchange chromatography, affinity-purified protein was diluted with IEX-
buffer 1 (20 mM Tris-HCl pH 8.0, 5% glycerol) to obtain a sodium chloride and 
imidazole concentration of less than 100 mM. The protein was loaded on a MonoQ 
5/50 (GE Healthcare) equilibrated with IEX-buffer 2 (IEX-buffer 1 + 50 mM NaCl) 
and eluted with a linear gradient of up to 1 M NaCl.  
The affinity- or ion-exchange-purified proteins were concentrated using Amicon 
Ultra Centrifugal Filters, (MWCO: 50 kDa or 100 kDa) and loaded on a size exclusion 
chromatography column (GE healthcare). Depending on the molecular weight of the 
target protein/target complex either Superdex 75, Superdex 200 or Sephacryl 400 
16/60 columns (HiLoad; GE healthcare) were used, which were pre-equilibrated with 
SEC-buffer 1 (20 mM Tris-HCl pH 8.0, 100 mM NaCl, 5% glycerol) or SEC-buffer 2 
(20 mM HEPES pH 7.5, 100 mM NaCl, 5% glycerol). In general, SEC-buffer 1 was 
used. SEC-buffer 2 was used only if subsequent biochemical analysis was 
incompatible with the Tris-HCl buffer. 
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5.3 Chemical cross-linking 
25% glutaraldehyde (GA) solution was used for chemical crosslinking experiments. 
Prior to cross-linking, proteins were transferred into cross-linking buffer (20 mM 
HEPES, pH 7.5, 100 mM NaCl, 5% glycerol) and diluted to 0.5-1 mg/ml. GA was 
added with different concentrations in the range of 0.01%-0.1% (v/v) to protein 
solutions. The reaction was stopped at different time points by the addition of Tris-
HCl (pH 8.0) to a final concentration of 100 mM. Cross-linking results were 
subsequently analysed by SDS-PAGE. 
 
5.4 Electron microscopy  
All electron microscopy experiments were carried out by Ekaterina Shimanovskaya 
(negative staining and image acquisition) and Marlene Brandstetter (rotary metal 
shadowing and image acquisition).  
For all negative staining experiments protein at a concentration of approximately 100 
µg/ml was adsorbed to glow-discharged grids and stained for 1 minute using 2% 
uranyl acetate with unadjusted pH.  
Image acquisition was done on a Morgagni 268D electron microscope (FEI) at 80 kV. 
Image analysis was done using ImageJ (http://rsbweb.nih.gov/ij/). 
 
5.5 Liposome binding assay 
Liposomes were generated from Folch Type I lipids (Sigma, gift from the Martens lab 
at the MFPL), containing phosphatidylinositol, phosphatidylserine and other lipids. 
In short, 1 mg Folch type 1 lipids were mixed with 100 µl chloroform (Merck) and 
dried under argon stream.  They were resuspended in binding buffer (20 mM Tris-
HCl pH 8.0, 100 mM NaCl, 5% glycerol) to give a final concentration of 1 mg/ml, 
followed by repeated filtration through a 0.4 µm polycarbonate filter (Whatman, 
Nucleopore track-etch). Purified protein (10 µg) was incubated with freshly generated 
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liposomes for 30 minutes at room temperature prior to ultracentrifugation. Samples 
were centrifuged for 10 minutes at 68000 rpm using a TLA100 rotor (Optima TLX 
Ultracentrifuge, Beckman). The supernatant was collected and pelleted liposomes 
were resuspended in equal volume of binding buffer. Both supernatant and pellet 
were analysed on a coomassie-stained SDS-PAGE gel as well as by anti-His Western 
blot. 
 
5.6  Western blot 
Protein bands were transferred to the PROTRAN nitrocellulose membrane 
(Whatman) using a trans-blot semi-dry transfer cell (BioRad). Primary antibodies 
used were anti-His (1:1000; Calbiochem) or anti-DnaK (1:10000; Enzo) antibody. 
Anti-mouse IgG (H+L) alkaline phosphatase (1:10000; Promega) was used as a 
secondary antibody, using SigmaFAST BCIP/NBT tablets (Sigma) to develop the blot.  
 
5.7 N-terminal sequencing  
N-terminal sequencing was done at the Tuft Core facility (physiology department, 
Stearns Bldg. Rm 808 136 Harrison Ave, Boston, USA). The protein of interest was 
blotted to an Immobilion P-membrane (Milipore) and the respective band was 
clipped. To increase the blotting efficiency following protocol was used. Prior to 
blotting, the polyacrylamide gel was equilibrated in cathode buffer (25 mM Tris-HCl 
pH 9.4, 40 mM glycine, 10% methanol) for 15 minutes. Simultaneously, the 
membrane was prepared for blotting by soaking in 100% methanol for 15 seconds, 
washing in water for 2 minutes and equilibrating in anode buffer 2 (25 mM Tris-HCl 
pH 10.4, 10% methanol) for 5 minutes. The gel and the membrane were assembled 
between filter paper pre-wetted in anode buffer 1 (0.3 M Tris-HCl pH 10.4, 10% 
methanol) at the bottom and cathode buffer at the top, and run for 2 hours at 25 V 
with trans-blot semi-dry transfer cell (BioRad). 
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5.8 Mass spectrometry 
Mass spectrometric analysis was done by the mass spectrometry facility of the Max F. 
Perutz Laboratories (Dr. Bohr-Gasse 3, 1030 Vienna, Austria). To avoid 
contamination by other proteinaceous materials, SDS-PAGE gels were prepared from 
fresh solutions and stained shortly with filtered coomassie staining solution. Desired 
bands were cut out in a sterile hood. A gel piece of an empty control lane was cut as a 
control sample.  
 
5.9 TCA precipitation 
TCA precipitation was done according to a protocol from Irene Gösler (Blaas lab, 
MFPL, Vienna). Briefly, 50% trichloroacetic acid (TCA) was mixed with the protein 
sample at a ratio of 1:4 and incubated on ice for 15 minutes. Protein was pelleted by 
centrifugation for 5 minutes at 14,000 rpm in a tabletop Eppendorf centrifuge. After 
discarding the supernatant, the pellet was washed by 300 µl of 20% ethanol and 
centrifuged again. This step was repeated twice. In the final step, the pellet was dried 
in a speed vac and resuspended in 10 µl respective sample buffer. 
 
5.10  Linear sucrose gradient 
Linear sucrose gradients were prepared using a gradient mixer, gradient station ip 
(BioComp; Marlovits lab, IMP, Vienna), in SW60 tubes. Gradients from 5-25% 
sucrose in sample buffer (20 mM Tris-HCl pH 8.0, 100-300 mM NaCl, 5% glycerol) 
were prepared at room temperature and cooled down for 1 hour at 4°C prior to 
centrifugation. Protein samples (<100 µl) were applied carefully onto the top of the 
gradient and centrifuged for 3.5 hours at 50000 rpm (TH-660 rotor, Sorvall 90 SE). 
A peristaltic pump was utilised to collect fractions between 300-400 µl (11 drops). 
Protein distributions along the gradient were analysed on an SDS-PAGE gel.   
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5.11  Additive test 
Different additives (Table 3) were tested to check their influence on the 
oligomerisation state of IFT20. Purified protein was incubated with the chemicals for 
one hour at room temperature prior to loading on a 5% native-PAGE gel. 
Table 3 Additive list. 
Additives Final concentration Additives 
Final 
concentration 
Urea 1 M Np-40 0.5 % (v/v) 
300 mM,  Ammoniumsulfate 300 mM Sodium chloride 
1 M Potassium chloride 1 M 
CHAPS 5 mM PEG-8K 10% 
1 mM, EDTA 1 mM Dithiotreitol 
10 mM Magnesium chloride 200 mM 
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6 Results 
6.1 Cloning of the 8 genes of the T. brucei IFT complex B core 
Reconstitution of the complex B core from T. brucei was done in a bacterial 
expression system. To avoid the expression of insoluble or aggregated individual 
subunits, I opted for a strategy that allowed me to co-express all eight subunits 
together. The pETDuet system (Novagen) consists of four vectors – pETDuet, pCDF, 
pCOLA and pACYC, each carrying compatible replicons and different selection 
antibiotics (Figure 6).  
 
Figure 6 Expression of the Tb IFT-B core using the pETDuet system. (a-d) The eight different genes 
were cloned into the respective vectors as displayed. Expression of each set of subunits was tested separately in a 
small-scale expression test. The asterisk marks a degradation product of IFT46. 
Using a stepwise approach, the IFT genes were cloned into one of the two multiple 
cloning cassettes (MCS) per vector. IFT74 and IFT81 were cloned into the same 
vector, based on the known interaction of these two subunits (Lucker et al., 2005).  At 
the time when we designed the experiment, IFT46 and IFT52 were proposed to 
directly interact with each other, so they were grouped together into the pETDuet 
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vector. The remaining subunits were cloned solely based on available and/or optimal 
cloning sites for each gene.  
Due to a cloning mistake, IFT27 was not expressed during the initial experiments. 
Even after re-cloning, the expression level of IFT27 was much lower than that of 
other core members (Figure 6d). It was reported previously that the majority of the 
sub-complex of IFT27 - IFT25 is not associated with the remaining IFT complex B 
outside the flagellum (Wang et al., 2009). Since I was able to pull-down the 
remaining subunits in the absence of IFT27, IFT27 is seemingly not essential for the 
assembly of the remaining recombinant complex proteins.  
For IFT46, in the N-terminal, unstructured region a substitution (M45I) was present 
in all clones. The Chlamydomonas homologue of IFT46 does not depend on its first 
89 amino acids in order to be able to bind to its binding partner IFT52 (Lucker et al., 
2010). All sequenced clones of IFT74 contained an insertion of a six amino acid motif 
(‘PGSQMR’) in the N-terminal region after amino acid R35. While this six-residue 
motif ‘PGSQMR’ is repeated three times in the published IFT74 sequence, it is 
repeated an additional fourth time in the used construct.  
In order to co-express all subunits together, the four constructs were co-transformed 
into one host cell, BL21(DE3). Initially, all co-transformation trials of the four 
plasmids together did not succeed, even though they were done according to the 
protocol from Novagen. To circumvent this problem, I opted to co-transform only 
two vectors at a time. Bacteria containing the two plasmids were used to prepare new 
chemically competent cells and the remaining two vectors were co-transformed into 
these cells. This approach proved successful as indicated in the expressions of all 
proteins together in one host cell shown below (Figure 7a). 
 
6.2 Co-expression in a heterologous bacterial expression 
system 
To purify the core complex from E. coli cell lysate, IFT46 and IFT81 were cloned with 
a C- and an N-terminal 6"His tag, respectively. In a small-scale expression test of 
each individual vector containing two complex B core members, the expression of all 
 47 
subunits was observed (Figure 6). With the exceptions of IFT27 and IFT22, the 
expression levels of other proteins were comparable. IFT22 was much more 
abundantly expressed than IFT27 (Figure 6d). 
For IFT46 and IFT52 (in pETDuet vector) an extra faint band was observed at 
approximately 38-39 kDa (Figure 6a). This band could also be detected via anti-His 
Western blot analysis (Figure 7a), suggesting that it represents either an N-terminal 
degradation product of IFT46 or a C-terminal one of IFT81. To sort this out and to 
find the proteolysis site, the band was cut and sent for N-terminal sequencing (Figure 
7b), which showed that the first six amino acids are ‘SLKNNP’, with high confidence 
for the second, third and fifth residue. With the exception of the first residue serine, 
the other five amino acids are found in the IFT46 sequence from position 98 
onwards. Thus, the first 97 amino acids of IFT46 are enzymatically degraded after 
expression, giving rise to the shorter band of a theoretical molecular weight of 38 
kDa, consistent with the observed band. Analysing the secondary structure of IFT46 
suggested that the first ~175 amino acids are disordered and likely more accessible 
for proteolytic degradation. 
 
6.3 Purification and verification of the recombinant complex 
To test whether the recombinant proteins are able to form a stable complex, IFT88, 
IFT74, IFT52, IFT25, IFT22 and, in later experiments, IFT27, were pulled down via 
their interaction with IFT46-His and His-IFT81 (Figure 7a, c).  
Initial purification trials were done using gravity affinity purification.  Tests of 
different metal ions in their ability to bind the 6"His tag indicated that copper and 
zinc are more effective than nickel and cobalt. Thus, either Zn2+ or Cu2+ charged 
affinity media was used in the initial purification step of the recombinant complex. 
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Figure 7 Reconstitution of the IFT complex B core. (a) Zn2+ affinity chromatography was used to capture 
both IFT46-His, His-IFT81 and other 5 core-subunits. Commassie-stained SDS-PAGE and Western blot were 
used to detect the proteins of interest. (b) N-terminal sequencing identified a degradation product of IFT46. The 
asterisk marks the degraded IFT46 in (a). (c) Schematic representation of the recombinant complex captured on 
the affinity matrix. 
Due to their similar molecular weights, IFT81 and IFT88 bands are overlapped on the 
SDS-PAGE gel if acrylamide above 10% (w/v) was used (Figure 7a). A strong band at 
around 74-75 kDa was observed that was initially suggested to be IFT52 based on its 
theoretical molecular weight. Surprisingly, however, this band was also detected on 
an SDS-PAGE gel during the purification of IFT74-IFT81 alone, although it is less 
intense than in the co-expression experiments of the core proteins. Therefore, I used 
mass spectrometry (MS) to identify the unknown band as well as to verify the other 
protein bands of the IFT complex B core. The overlapped IFT88 and IFT81 bands 
were cut together and both proteins were correctly identified by MS, as were IFT74 
and IFT22. The band corresponding to IFT46 was not sent for MS, since it had 
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already been identified by anti-His Western blot. Interestingly, a few polypeptides 
matching IFT46 were detected in the IFT22 MS results. Although both proteins have 
different molecular weights, fragments of IFT46 might have migrated together with 
IFT22 on the SDS-PAGE, thus giving rise to the identified peptides. MS-analysis of 
the IFT52/unknown band revealed two prominent proteins. Aside from the expected 
IFT52, the E. coli chaperone protein DnaK (protein ID 15799694) was also detected. 
As mentioned earlier, chaperones can be found at the flagellar tip and the 
Chlamydomonas chaperone Hsc70 is able to interact with IFT components 
(Bhowmick et al., 2009).  A BLAST search showed a sequence identity between E. coli 
DnaK and T. brucei Hsp70 of 49%. It is not clear if the co-purification of DnaK is 
based on its folding activity of potential unfolded sequences in the target complex or, 
in the absence of the chaperone Hsp70, DnaK mimics Hsp70 to bind to one or several 
of the core proteins. 
During all purifications, IFT27 and IFT25 were low abundant and could not be 
verified by MS. Aside from mass spectrometry, IFT46 and IFT81 (as well as the N-
terminal degradation product of IFT46) were also verified via Western blot analysis, 
using anti-His antibody (Figure 7a, lower panel). To further improve the affinity 
purification, IFT81 was cloned with a FLAG-tag (sequence: DYKDDDDK). 
Interestingly, it was not possible to elute the majority of the complex from the FLAG-
beads. Only minor fractions of the proteins eluted, independently of the used elution 
method. Therefore, 6"His-tagged IFT81 was used for all subsequent purifications of 
the complex.  
To remove the E. coli chaperone protein DnaK from the reconstituted complex, 
addition of 5 mM Mg2+-ATP, both in the presence and absence of a mixture of 
denatured E. coli proteins, was tested (Rial and Ceccarelli, 2002). Denatured proteins 
were produced from BL21 cell lysate by heating the supernatant for 10 minutes to 
90°C. Both approaches improved the removal of DnaK, suggesting that - at least to 
some extent - DnaK is associated with the complex via its chaperone function. I also 
found that a two-step imidazole gradient during the initial affinity chromatography 
step (carried out on an FPLC system) was effective in removing DnaK (Figure 7a). 
The chaperone could be mostly removed during a flat gradient from 50-70 mM 
imidazole, whereas the recombinant complex subsequently eluted together in a 
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second peak from the affinity matrix containing 150-200 mM of imidazole (Figure 
7a).  
 
6.4 Assessment of the oligomeric states 
To assess the oligomeric state and the homogeneity of the affinity-purified proteins, 
size-exclusion chromatography was used. The proteins consistently co-eluted in a 
shoulder peak, ranging from 5 MDa to approximately 600 kDa (Figure 8). If present, 
IFT27 seemed to be low abundant and could not be clearly detected on the SDS-
PAGE, which was similar to IFT25.  A current model suggests that the core complex is 
composed of two copies of IFT81 and IFT74, and one copy of each of the remaining 
members. This would correspond to an assembly with a molecular weight of 
approximately 570 kDa (‘single complex’). The data shown here indicates that the 
complex core has different oligomeric states, ranging from the current working model 
up to larger particles and potential aggregates. The composition of the higher 
oligomeric assemblies is unknown. Due to the high heterogeneity of the complex 
observed on the size-exclusion chromatography, the sample was not suitable for 
crystallisation trials. To improve the purification, arginine and glutamic acid were 
added following a protocol that has been shown to work in other protein purifications 
(Golovanov et al., 2004). However, no change in the elution profile was observed. 
Interestingly, upon addition of CaCl2 and MgSO4 (Bhogaraju et al., 2011), a small shift 
towards the ‘single complex’ was observed (Figure 8b), with less protein in the void 
volume compared to the normal buffer (Figure 8a).  
Aside from the heterogeneity of the complex, expression yields of the eight subunits 
were not consistent. Different batches of purified core complex had significant 
variations in the amount of pure proteins. Therefore, low yield and heterogeneity of 
the reconstituted complex prevented the successful crystallisation of the core 
complex.  
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Figure 8 Size-exclusion chromatograms of IFT complex B core proteins after affinity purification. 
(a) The core proteins, except for IFT27, were loaded on the gel filtration column Sephacryl 400 (16/60). IFT25 
was low abundant. (b) All eight proteins were co-purified in a buffer containing MgSO4 and CaCl2. IFT27 and 
IFT25 could not be detected. (a,b) Equal amounts were loaded on the SDS-PAGE. (c) SEC elution profile after 
removing potential lipid contamination using b-OG. Lanes 1 and 2 were respectively loaded with 25% and 50% of 
the amount loaded in the remaining lanes. 
During multiple size-exclusion purifications of the core subunits it was observed that 
the UV absorbance at 280 nm did not correspond to the protein amount on an SDS-
40 60 80 ml
80
120
mAU Sephacryl-400
10
40
2
150
100
75
50
37
25
20
15
1 2
IFT81+88
IFT52+74
IFT46
IFT46*
IFT22
0 20 40 60 80 ml
0
50
100
150
mAU Sephacryl-400
100
75
50
37
25
20
15
IFT81+88
IFT52+74
IFT46
IFT46*
IFT22
2
1
CaCl2, MgS04
ba
2
1
100
75
50
37
25
20
15
IFT81+88
IFT52+74
IFT46
IFT46*
IFT22
0 20 40 60 80 ml
0
40
80
120
mAU Sephacryl-400
1
b-OG wash
2
c
1 2
 52 
PAGE (Figure 8a & b, SDS-PAGE gels). Since lipids have a UV absorbance at 280 nm 
but could not be stained on an SDS-PAGE, it could be possible that they were present 
in the observed aggregation peak. To remove the potential lipid contamination, I 
washed the complex bound to the affinity matrix using buffers containing either 1% 
Triton X-100 or 30 mM n-octyl-b-D-glucoside (b-OG) before eluting the 
polypeptides. The SEC-elution profile of the complex washed with b-OG during the 
affinity purification (Figure 8c) showed a more defined nonaggregated peak after the 
void-volume peak, similar to the purification results with CaCl2 and MgSO4 (Figure 
8b). 
6.4.1 Linear Sucrose Gradient 
Large protein complexes are often purified using density centrifugation as an 
alternative to size-exclusion chromatography. To test whether this approach could be 
more suitable for separating the recombinant IFT complex B core, linear sucrose 
gradient ultracentrifugation was used (Figure 9). The affinity-purified proteins were 
loaded on the gradient. All fractions were analysed on a SDS-PAGE gel. The top 
fractions, containing low molecular weight proteins or molecules unable to enter the 
gradient, showed a strong band of around 24 kDa, which is likely an E. coli protein. 
The majority of the core proteins co-migrated in the gradient, with the major peak 
appearing in fractions 4-6 from the top of the gradient. Most of the proteins could be 
observed in all fractions of the gradient. This is consistent with the SEC data that 
showed different oligomeric states of the core complex (Figure 8).  
To test whether the T. brucei homolog of DnaK, Hsp70, is capable of binding to the 
complex, MBP-tagged Hsp70 was co-expressed with the complex. Interestingly, the 
gradient fractions 4-6, where the core complex was peaking, were the fractions with 
the least amount of Hsp70 (Figure 9b). The majority of Hsp70 was found at the 
bottom of the gradient. These results show that Hsp70 associates with the larger, 
potentially aggregated fractions of the IFT-B core complex, but not with the ‘single 
complex’.  
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Figure 9 Linear sucrose gradient ultracentrifugation.  (a) All eight affinity purified proteins were loaded 
on the sucrose gradient. (b) The eight core proteins co-purified with MBP-Hsp70 were affinity purified and loaded 
on the sucrose gradient. Fractions were collected using a peristaltic pump. 
 
6.5 Expression of the recombinant complex in a DnaK 
deletion strain 
To investigate potential differences in the expression of the core-complex in the 
absence of DnaK, the DnaK deletion strain EN2 was tested (Ratelade et al., 2009). 
Due to the kanamycin selection marker of this cell line, our pCOLA vector containing 
IFT27 and IFT22 could not be co-transformed. Thus, purification of only IFT88, 
IFT81, IFT74, IFT52, IFT46 and IFT25 was tested. The six-protein complex was 
purified using Cu-NTA affinity chromatography. The suppression of DnaK in this cell 
line was verified with anti-DnaK Western blot analysis (Figure 10b). The affinity 
purified 6-protein complex from EN2 cells was used for Western blot. A strong signal 
for DnaK was detected for the control BL21-cells but none for the core complex 
expressed in EN2 cells. Thus, DnaK is successfully suppressed in the EN2 cell line.  
Size-exclusion chromatography showed a similar elution profile of the complex 
compared to previous purifications in BL21(DE3) (Figure 8, Figure 10a), indicating 
no influence of DnaK on the oligomeric state of the complex. A chemical cross-linking 
experiment with glutaraldehyde showed the cross-linking of the six core-subunits. 
The cross-linked band had a very large molecular weight and could only be seen at 
the top of the gel (Figure 10c). 
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Figure 10 Test of protein expression in the DnaK-deletion EN2 cell line (a) Affinity-purified complex 
was loaded on a Sephacryl-400 (16/60) column. For the SDS-PAGE, equal amounts of sample were loaded for 
peak 2 and 3. For lane 1, a third of the sample volume was loaded compared to other fractions. (b) Anti-DnaK 
Western blot. Bl21(DE3) cell lysate was used as the positive control. (c) Chemical cross-linking using 0.05% 
glutaraldehyde (GA) for 1 minute at room temperature. The red arrow marks the high-molecular weight species 
that was unable to enter the gel. (d) Peak 2 of panel (a) was combined and used for negative staining electron 
microscopy studies. Scale bar (red): 20nm 
Fractions from size-exclusion chromatography (Figure 10a, peak 2) were used for 
negative staining EM studies (Figure 10d) to check whether the sample contains 
prominent structures that represent the complex composed of IFT88, IFT81, IFT74, 
IFT52, IFT46 and IFT25. Roundish particles, between larger, dark assemblies, could 
be observed with sizes between 10 and 16m. If an overall globular shape of the 
complex were assumed, structures with a diameter of approximately 10.7 nm would 
be expected. Further studies are needed to verify if the particles are IFT complex B 
core proteins or may be liposomal contamination. 
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6.6 IFT74 and IFT81 form a stable sub core-complex and 
interact with Hsp70 
Yeast-two hybrid studies have shown the interaction between Chlamydomonas 
IFT74 and IFT81 (Lucker et al., 2005). To investigate whether the homologous 
proteins in T. brucei also interact in a recombinant system, IFT74 and IFT81 in pCDF 
were co-expressed and co-purified. Furthermore, the interaction of the two proteins 
with MBP-Hsp70 was tested. Zn2+-affinity chromatography was used to capture His-
IFT81 and its binding partner IFT74. MBP-Hsp70 is also pulled-down (Figure 11a). 
To exclude that Hsp70 is only binding to IFT81-IFT74 via its chaperone function, 4 
mM ATP and 20% glycerol were added to the buffers. No difference in the binding of 
the three proteins was observed (Figure 11d).  
Alternatively, amylose beads were used to pull-down MBP-Hsp70 and associated 
molecules (Figure 11b). Interestingly, only MBP-Hsp70 was strongly enriched on the 
amylose beads. This is probably due to the much higher expression level of MBP-
Hsp70 compared to IFT81 and IFT74 and only a fraction of the expressed MBP-
Hsp70 is binding to IFT74-IFT81 in solution. 
To check the homogeneity and stochiometry of the hetero-trimeric complex, the Zn2+-
purified macromolecules were loaded on a size-exclusion column. Two different 
peaks were observed, aside from an aggregation peak in the void volume of the 
column (Figure 11c). Peak number 2 showed the trimeric assembly at a molar ratio of 
1:2:2 (Hsp70:IFT81:IFT74). Seemingly, the heterotetramer of 2xIFT81 and 2xIFT74 
binds to one molecule of Hsp70. The third peak contained excess Hsp70, although 
trace amounts of IFT81 and IFT74 were also detected. The 1:2:2 stochiometry of the 
trimeric complex and the higher expression levels of MBP-Hsp70 explain the minor 
amounts of IFT74 and IFT81 that were captured by Hsp70 on the amylose beads 
given the much higher level of Hsp70 than the two IFT proteins (Figure 11b). The 
trimeric complex was examined by rotary shadowing electron microscopy to study 
the arrangement of the three proteins, but no consistent structures were observed on 
the grids (data not shown). 
 56 
 
Figure 11 Purification of the IFT74/IFT81/Hsp70 complex.  (a,b) Cell lysate was split half/half and 
separately loaded on a Zn-HiTrap column and an amylose resin. SDS-PAGE gels show the flow-through and (a) 
eluted proteins or (b) the amylose-bound proteins. (c) The eluent of the Zn2+ affinity purification was loaded on a 
Sephacryl-400 (16/60) column and fractions were analysed on an SDS-PAGE gel. (d) Zn-NTA HiTrap elute 
fractions, where prior to elution a wash with ATP and glycerol had been included or not. 
 
6.7 The IFT complex core proteins bind lipids 
To elucidate whether the complex is capable of binding lipids, liposome-binding 
assays were conducted (Figure 12). A size-exclusion chromatography peak fraction of 
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the core complex (where a detergent wash had been included during the prior affinity 
chromatography step) was analysed. Western blotting using anti-His antibody 
showed that IFT46 was pulled down by liposomes (Figure 12b). IFT81 was not 
detected in any fraction, which could be due to an unsuccessful transfer onto the 
nitrocellulose membrane or insufficient expression.  
 
Figure 12 Liposome binding assay. (a) Schematic representation of the liposome binding assay. (b) Purified 
IFT complex B core proteins were incubated with liposomes. Supernatants (sn) and pellets (P) were run on a 12% 
SDS-PAGE and IFT46 was detected by anti-His Western blotting. (c) The purified protein sub-complex composed 
of IFT74, IFT81 and Hsp70 was used for the liposome binding assay. The majority of the complex proteins were 
pulled down by liposomes. 
The sub-core complex consisting of IFT74 and IFT81 together with the potential 
binding partner Hsp70 was also tested. MBP-Hsp70, IFT81 and IFT74 were only 
pelleting in the presence of liposomes. While all IFT81 and IFT74 proteins bound to 
liposomes, only ~60% of MBP-Hsp70 was pelleted. The un-pelleted Hsp70 is likely to 
represent the fraction of the polypeptide that is not bound to IFT74-81. The results of 
sub-core complex of IFT74 and IFT81 indicate a liposome-binding capability. In 
conclusion, the complex core proteins are able to bind to liposomes.  
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6.8 Analysis of the peripheral IFT-B subunit IFT20 
Among all components of the IFT complex B, the peripheral subunit IFT20 is the 
only one localising to the trans-Golgi network. It was suggested to be involved in the 
selective transport of cilium-destined vesicles to the ciliary base. The unique 
distribution pattern and the relatively small size of IFT20 make it an intriguing target 
for structural studies.  
IFT20 from T. brucei was cloned to a homemade vector (HM15b), which provides a 
cleavable N-terminal 6xHis-tag. Secondary structure analysis predicted the protein to 
be composed mainly of "-helices. Moreover, 50% of the protein was computed to 
assemble into a coiled coil (Figure 13). 
 
Figure 13 Bioinformatic analysis of IFT20. (a) Using the secondary structure prediction server PSIPRED 
(Buchan et al., 2010; see section 9), the amino acid sequence of IFT20 was analysed. Pred = prediction (b) The 
online software COILS (Lupas et al., 1991; see section 9) was used to compute the probability of IFT20 to 
assemble into coiled coils. 
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Initial purification was carried out using Ni-NTA affinity chromatography. To remove 
minor impurities, the protein was subjected to an ion-exchange chromatography 
prior to SEC. The protein eluted in two peaks on a gel filtration column – dimer and 
tetramer, with the predominant amount of the protein being in a tetrameric state 
(Figure 14a). 
 
Figure 14 Purification and characterisation of T. brucei IFT20. (a) The Ni-NTA affinity purified IFT20 
was loaded on the size-exclusion column Superdex-75 (16/60). Two distinguishable peaks with different amounts 
of protein were observed. (b) Fractions of the SEC-run of panel (a) were analysed on a 5% native gel. (c) Different 
additives were added to the purified protein and samples were loaded on a native-PAGE to check for the influence 
of the additives onto the protein oliogomeric states. (d) Different concentrations of CHAPS were tested.  
To assess the homogeneity within both peaks, a native gel was run. A clear shift 
between the two species can be observed (Figure 14b). The dimeric fractions contain 
trace amounts of the tetrameric protein and vice versa. To further investigate whether 
it is possible to shift the oligomerisation states of IFT20, different additives were 
tested. Fraction of tetrameric IFT20 were incubated with the additives and analysed 
on a native polyacrylamide gel. Among the diverse set of chemicals, CHAPS resulted 
in a strong shift from the tetrameric to the dimeric state (Figure 14c, a subset of 
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additives is shown here). Different concentrations of CHAPS and the influence on the 
tetramer to dimer shift were studied. While 3 mM CHAPS did not result in a 
significant change, 10 mM CHAPS shifted IFT20 nearly completely into the dimeric 
state (Figure 14d). It is worth noting that 10mM corresponds to the critical micelle 
concentration of CHAPS. However, re-purifying IFT20 in a buffer containing 10mM 
CHAPS, resulted in a different elution profile, with a 50:50 ratio of tetramer and 
dimer (Figure 15a).  
 
Figure 15 Re-purification of T. brucei IFT20 in the presence of CHAPS. (a) An SEC elution profile of 
the re-purified IFT20 in the presence of 10mM CHAPS. Equal amounts were loaded on the SDS-PAGE. The arrow 
marks IFT20. (b) Re-loading either peak 1 (“tetramer”) or peak 2 (“dimer”) in (a) on an analytical gel filtration 
column Superdex 200 (10/300).  
Subsequently, re-purifying IFT20 in a buffer containing 10mM CHAPS, resulted in a 
different elution profile, with a 50:50 ratio of tetramer and dimer (Figure 15a). 
Interestingly, re-loading either the dimeric or the tetrameric IFT20 on an analytical 
size-exclusion column showed the protein to elute again in two peaks (Figure 15b), 
indicating that the protein is in equilibrium between the two states. Crystallisation 
trials of IFT20 with and without the addition of CHAPS were conducted, but no 
crystals have been obtained. 
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7 Discussion 
Since the discovery of intraflagellar transport in 1993 (Kozminski et al., 1993), 
tremendous advances in understanding the principles of the process have been made 
(Blacque et al., 2008; Finetti et al., 2009; Sedmak and Wolfrum, 2010). However, the 
structural mechanism of IFT still remains largely unclear. It is possible to isolate the 
IFT complexes from Chlamydomonas but the yield and the purity are inadequate for 
structural studies (Behal et al., 2009). To circumvent both the impurity and the low 
yields, a co-expression strategy has been taken to produce individual proteins of the 
IFT complex B core in a bacterial expression system. The pETDuet system allowed us 
to co-express the entire eight core proteins. Despite the shortcoming of not being able 
to co-transform the four plasmids at the same time, but rather in a stepwise process, I 
managed to express the recombinant core complex in bacteria. 
 
7.1 Reconstitution of the T. brucei IFT complex B core  
It was possible to purify the complex with affinity tags on only two of the 8 core 
subunits – IFT46 and IFT81. This shows that the subunits of the IFT complex B core 
purified from E. coli interact and assemble into a complex. Interestingly, Ni2+ was not 
sufficient in capturing the 6"His-tagged subunits. Other metal ions were tested and 
Zn2+ and Cu2+ were found to be better suited in binding the 6"His-tagged proteins. It 
has been published that Zn2+ is superior to Ni2+ metal affinity due to its reduced 
binding affinity for E. coli proteins (Gaberc-Porekar and Menart, 2001). Cu2+ on the 
other hand is known to bind to even a single exposed histidine.  
Six of the eight IFT complex B core subunits have been verified either via mass 
spectrometry or by anti-His Western blots. IFT27 and IFT25, which were both low 
abundant and hard to be recognised on an SDS-PAGE gel, were not verified with 
either method. IFT27 was significantly lower expressed than its expression partner 
IFT22 on the vector pCOLA (Figure 1d). In the recent publication by Bhogaraju and 
colleagues (Bhogaraju et al., 2011), they showed that recombinant CrIFT27 was 
strongly stabilised by its binding partner IFT25. It might be possible that in addition 
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to the low abundance, recombinant IFT27 is degraded easily. Future studies should 
include an affinity tag at the N- or C-terminus of IFT27 to test this hypothesis.  
As described previously, IFT27 and IFT25 are part of IFT complex B isolated from 
Chlamydomonas flagella (Cole et al., 1998; Wang et al., 2009; Lechtreck et al., 
2009). However, within the cytoplasm they can be found at a separate location from 
the other complex B proteins (Wang et al., 2009). It cannot be excluded that the 
recombinant complex might be less stable than its in vivo counterpart. Notably, both 
proteins are not conserved in C. elegans and D. melanogaster (Qin et al., 2007; 
Lechtreck et al., 2009). In conclusion, although detectable in small-scale 
experiments, IFT27 and IFT25 are less stably integrated into the core complex in the 
recombinant system used here than in vivo. The absence of IFT27 did not influence 
the purification of the other core proteins in a detectable manner. 
During the first affinity purification step, the E. coli chaperone protein DnaK was co-
purifying with complex B proteins as was verified by mass spectrometry. 
Interestingly, chaperone proteins of the Hsp70 family can be found at the flagellar tip 
region (Shapiro et al., 2005). Since their transport is likely to be mediated by IFT 
particles, it could be possible that DnaK binds to the complex in a similar manner as 
Hsp70-IFT interaction. The majority of DnaK can be removed from the complex 
during the affinity chromatography step, indicating that the binding is not strong. 
However, it cannot be ruled out that members of the recombinant complex are not 
completely folded, thus activating DnaK binding.  
 
7.2 Does the IFT complex B core assemble into structures 
similar to the IFT particle? 
During multiple size-exclusion purifications, it was observed that the complex 
consistently eluted in different oligomeric states. Aside from the potential “single 
complex”, the recombinant proteins seem to form higher order structures and/or 
large aggregates. Similarly, using linear sucrose gradient ultra-centrifugation as an 
alternative approach to gel filtration, the complex was found in all fractions, from the 
top of the gradient to the bottom, although the complex was more enriched in 
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fraction 4-6 from the top. It has to be noted, that the composition of the larger 
structures is unknown, in part due to the extended coiled-coil structures of IFT74 and 
IFT81 that prevent the measurement of the exact molecular weight of the 
recombinant complex by means of gel filtration. Using the DnaK deletion strain EN2 
to co-express IFT88, 81, 74, 52, 46 and IFT25 and to test the influence of the 
chaperone protein did not show a change in the purification. The complex still eluted 
in a large shoulder peak on the size-exclusion column, indicating again different 
oligomeric states. 
Studies have shown that trains of IFT particles with several single IFT-A and -B 
complexes arranged in a chain-like manner, move along the axoneme within the 
cilium (Pigino et al., 2009). Whether the reconstituted IFT complex B core assembles 
into similar larger structures even in the absence of IFT-A proteins is unknown but 
tempting to speculate. The different oligomeric states of the complex observed on 
size-exclusion chromatography proved to be one of the main obstacles for successful 
crystallisation. A homogeneous protein sample is indispensable for crystal growth. 
Therefore, many of my efforts have focused on obtaining a more homogeneous 
sample. Arginine and glutamic acid have been shown to improve solubility and long-
term stability of other proteins (Golovanov et al., 2004). However, no significant 
difference in the elution profiles of the core complex upon the addition of these 
additives was noted. Recently, the crystal structure of IFT27-25 was published 
(Bhogaraju et al., 2011). In their purification protocol, CaCl2 and MgSO4 were added 
to all buffers. When I used both additives during a purification of the complex, a 
more defined peak of the ‘single’ complex was observed (Figure 8b).  
7.2.1 Hsp70 associates with the higher oligomeric assemblies 
Interestingly, purifying IFT88, -81, -74, -52, -46 and -25 together with Hsp70 in EN2 
cells on a sucrose gradient showed that Hsp70 is not part of the fraction of the 
complex that migrates to the middle of the gradient. Hsp70 was exclusively found in 
the bottom fractions (Figure 9b). This implies that this part of the core complex may 
be aggregated and Hsp70 is associated with the proteins via its chaperone function.  
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7.3 Obstacles during the reconstitution of the IFT complex B 
core 
The two biggest obstacles during the purification of the complex were the large yield 
fluctuations and reproducibility problems. Whether glycerol stocks or a fresh 
transformed cell were used, protein yield was inconsistent and independent of the 
amounts of grown cells. Inducing the cells at an O.D. of 0.9-1 stabilised the yield to 
some extent. Although I have managed to partially purify the recombinant complex B 
core from E. coli, the observed inconsistent yield and sample heterogeneity indicate 
that a eukaryotic expression system might be better suited for producing the core 
complex. Post-translational modifications might be able to stabilise the assembly and 
enable the purification of a less heterogeneous sample. For insect cell expression, the 
multiBac system (Berger et al., 2004) would be a reasonable approach to co-express 
the eight-proteins of the core complex. Once the expression can be verified, it is 
possible to scale up the protein yield for biochemical and structural studies. In 
addition to the core-complex, other sub-core complexes, such as IFT46-IFT52 with or 
without IFT88, are also worth to be studied by protein crystallography (Lucker et al., 
2010).  
As an alternative to crystallisation, electron microscopy studies could give some 
insights into the overall 3-dimensional architecture of the IFT complex B core. In 
recent years, methods to prepare samples with better homogeneity and higher 
stability for EM studies have been developed. Kastner and colleagues introduced the 
“GraFix” method that uses a sucrose gradient with simultaneous cross-linking to 
generate homogeneous particles for subsequent EM analyses (Kastner et al., 2008). 
Another method published recently presented a protocol for successful blotting of 
protein complexes from native PAGE onto the carbon grid (Knispel et al., 2012). Both 
approaches would be feasible for EM studies of the recombinant IFT complex B core 
by generating a more homogeneous sample for subsequent analyses. 
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7.4 Sub-core complex of IFT74 and IFT81 binds the 
chaperone protein Hsp70 
Yeast-two hybrid assays have shown that IFT74 and IFT81 from Chlamydomonas 
directly interact with each other (Lucker et al., 2005). Both subunits from T. brucei 
together with the chaperone protein Hsp70 were analysed in this study. 6"His-tagged 
IFT81 was able to pull down both IFT74 and Hsp70. Due to the MBP-tag on Hsp70, 
the fusion protein was more expressed than IFT74 and IFT81 since MBP is known to 
improve both the solubility and the yield of a recombinant protein (Kapust and 
Waugh, 1999). On the size-exclusion chromatography, the majority of the three 
proteins were co-eluted with a 1:2:2 (Hsp70:IFT81:IFT74) stochiometry, i.e, one copy 
of Hsp70 binds to a tetramer of two copies each of IFT81 and IFT74 (Figure 11c). 
Given the stronger overexpression of MBP-Hsp70, it was not surprising that using 
amylose beads to capture MBP-Hsp70 resulted in an excess of MBP-Hsp70 over 
IFT81 and IFT74 (Figure 11b). No binding site of Hsp70 to either of IFT81 or IFT74 
has yet been identified. Nevertheless, the binding seems to be not based on the 
chaperone function of the Hsp70, since including ATP- and high glycerol washes on 
the Ni-NTA affinity column did not result in an altered binding of Hsp70 to IFT74 
and IFT81. Although the assembly seems to be stable to some extent, rotary 
shadowing experiments (data not shown) did not show a distinct structure of the 
complex proteins, which could be due to the mechanical stress during the grid 
preparation that disrupts the association between the three polypeptides.  
 
7.5 Lipid binding of the IFT complex B 
Part of the cargo destined for the cilium is transported in vesicles from the trans-
Golgi network to the ciliary base. IFT20, a peripheral subunit of the IFT complex B, is 
thought to be one of the key players in this process. However, how the cargo is loaded 
on the IFT particle for the subsequent transport into the cilium is yet unknown 
(Figure 16).  
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Figure 16 Vesicle trafficking from the Golgi to the cilium. IFT20 localises to the tans-Golgi network, 
where it interacts with GMAP210 (Follit et al., 2008). IFT20 is proposed to sort vesicles associated with molecules 
destined for the cilium; IFT20 is further involved with their correct transport to the ciliary base where they are 
fused to the plasma membrane to unload ciliary components (Follit et al., 2009). 
In a preliminary experimental test, I have shown that the recombinant complex B 
core was able to bind to liposomes (Figure 12b, c). It is possible, that one or more of 
its subunits are the tethering points for vesicles. Given that the IFT74/81/Hsp70 
complex could be pulled down by liposomes, at least IFT74 and/or IFT81 provide 
part of the lipid contact site. Whether other core-proteins might also attach to 
liposomes awaits further studies. Additionally, it should be investigated whether the 
types of lipids used to generate the liposomes have an influence on the binding of the 
IFT-B core. 
 
7.6 IFT20 is in equilibrium between dimers and tetramers 
IFT20 is a unique subunit of the IFT complex B since it is the only member also 
found to localise to the trans-Golgi network (Follit et al., 2006) (Figure 16). Previous 
studies have focused largely on the potential role of IFT20 in the transport of vesicles 
from the Golgi apparatus to their ciliary destination (Follit et al., 2006; Follit et al., 
2008) and its involvement with ciliary disorders (Jonassen et al., 2008).  
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Despite the small size of the protein, no structural information has been published 
yet. Here I have shown that the recombinant protein could be easily purified in a 
bacterial expression system.  The coiled-coil protein assembles into both a dimer and 
a tetramer. Whether this has any biological significance or is just a result of the used 
purification strategy is yet unknown. Interestingly, addition of CHAPS during the 
purification of the polypeptide resulted in less tetrameric IFT20 (Figure 15a). CHAPS 
is a zwitterionic detergent, normally used during the purification of membrane 
proteins (Raja and Vales, 2011). Adding the chemical in a concentration close to its 
critical micelle concentration (CMC) induced a partial shift of IFT20 to a dimer 
(Figure 14c, d). Moreover, IFT20 is in equilibrium between both states, as was 
observed upon re-loading the tetrameric or the dimeric protein, respectively, on a 
size-exclusion column (Figure 15b). These two states of IFT20 were probably the 
reason for the unsuccessful crystallisation attempts of the protein. As was observed 
with the IFT complex B core, a homogeneous sample is indispensable for successful 
crystallisation. In order to crystallise IFT20 it might be feasible to investigate co-
crystallisation with binding partners, like IFT54 (Omori et al., 2008) or IFT57 (Baker 
et al., 2003). The interaction could stabilise the polypeptide in one of its 
oligomerisation states and may thus facilitate protein crystallisation. 
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Part II:  
Structural characterisation of the coiled-coil domain of 
the cytolinker protein plectin 
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1 Abstract 
Plectin is a versatile cytolinker protein, whose unique domain organization allows it 
to cross-link the three main cytoskeleton components, intermediate filaments, actin 
and microtubules. Plectin is of special importance in hemidesmosomes and the z-
discs, where it acts as a stabilizer of the structure. A large set of mutations in plectin 
have been linked to the onset of the human disorder epidermolysis bullosa (EB). This 
disease manifests itself as a loss of skin integrity and occurrence of skin blisters. Most 
of the mutations have been identified as autosomal recessive with the exception of 
Ogna, a substitution of arginine to tryptophan in the coiled-coil domain of the 
protein. To investigate the influence of this single amino acid change on the 
functionality of plectin, I have carried out extensive biochemical, biophysical and 
structural studies on the recombinant coiled-coil domain plectin. The results 
indicated that the mutation mainly influences the oligomerization ability of plectin. 
Using electron paramagnetic resonance (EPR) study, the orientation of the coiled-coil 
protein was identified to be parallel and does not change upon introduction of the 
arginine to tryptophan mutation. Future studies will be needed to fully understand 
the influence of the single amino acid change on the integrity of plectin and the 
development of EB. 
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2 Zusammenfassung 
Plectin ist ein vielseitiges Zytolinker Protein und besitzt eine ideale Struktur um alle 
drei wichtigen Zytoskelett-Komponenten – Actin, Mikrotubuli und Intermediäre 
Filamente - miteinander zu verbinden. Es ist von besonderer Bedeutung in den 
Hemidesmosomen der Epidermis und den Z-Linien in den Muskelzellen, wo es als 
Stabilisator fungiert. Verschiedene Mutation in Plectin konnten mittlerweile der 
Krankheit Epidermolysis bullosa (EB) zugeordnet werden. Diese Krankheit zeichnet 
sich durch eine besondere Sensitivität der Haut auf jeglichen mechanischen Stress 
aus, gekennzeichnet durch Blasen- und Wundbildung der Epidermis. Die meisten der 
Plectin Mutationen werden autosomal rezessiv vererbt, mit Ausnahme einer 
Mutation von Arginin zu Tryptophan (R>W). Diese Substitution liegt in der Coiled-
coil Domäne des Proteins und ist bisher die einzige Mutation von Plectin mit einem 
dominanten Phänotyp. Um den Einfluß dieser einzelnen Aminosäurenänderung auf 
die Integrität und Stabilität von Plectin zu untersuchen, wurden verschiedene 
Abschnitte der Coiled-coil Domäne untersucht. Mittels Elektronenspinresonanz 
konnte festgestellt werden, dass das Protein ein paralleles Dimer ist, das sich 
unabhängig von der Mutation in dieser Orientierung bildet.  Interessanterweise 
scheint die Mutation R>W die Fähigkeit von Plectin zu beeinflussen größere 
Aggregate zu bilden. Inwiefern sich diese Beobachtung funktional mit der 
Entwicklung von EB korreliert, wird der Fokus zukünftiger Experimente sein. 
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3 Introduction  
3.1 Plectin 
As mentioned in the first part, one of the key architectural elements of the cilium is 
the microtubular axoneme (part I, chapter 3.2). Microtubules, together with the actin 
and the intermediate filaments, are the building blocks of the cytoskeleton, a complex 
network of protein fibers responsible for the cell’s shape and required for processes 
like cell division, intracellular traffic or movement of cells along surfaces - just to 
name a few. The different properties of each of these three proteinaceous groups give 
rise to the various functions the cytoskeleton comprises. Actin filaments, with a 
diameter of around 6 nm, microtubules with 23 nm and intermediate filaments about 
10 nm in width (Fuchs and Weber, 1994) are structurally stabilised and inter-linked 
by cytolinkers/accessory proteins. One versatile cytolinker family is the plakin family, 
with the main members being plectin (Figure 17, in green) and desmoplakin.  
 
Figure 17 Linking the cytoskeleton by plectin. Plectin (green) cross-links intermediate filaments (blue) to 
microtubules (red). Scale bar: 0.1 µm. Figure from (Svitkina et al., 1996). 
 
3.2  Domain organisation & structural information 
Plectin is a large cytolinker protein (approx. 500kDa), which was identified as 
intermediate filament binding partner and reported to share structural homologies to 
microtubule-associated proteins (MAPs) decades ago (Pytela and Wiche, 1980). 
Structurally, plectin can be dissected into three regions. (1) an amino-terminal 
globular domain consisting of an actin-binding domain and several spectrin repeats 
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(plakin domain), (2) a central coiled-coil rod with a length of around 200 nm (Wiche, 
1998), and (3) a carboxyl-terminal globular domain composed of 6 plectin repeats 
(Figure 18). EM analysis indicated that plectin has a dumbbell-like structure, as can 
be seen in Figure 17 in green, with the long coiled-coil rod enabling the linkage of 
distant binding partners (Steinböck and Wiche, 1999). Electron microscopy studies 
have clearly visualised plectin interacting with various cytoskeleton components 
(Svitkina et al., 1996), showing its versatility as a cytolinker. 
 
Figure 18 Domain organisation of full-length Mus musculus Plectin. The N-terminal globular domain 
contains binding sites for actin (red) and the spectrin repeats (blue). The C-terminal plectin repeats (yellow) 
include attachment sites for intermediate filaments. 
Plectin is able to bind to actin via its N-terminal domain (Seifert et al., 1992), which 
regulates the actin network (Andrä et al., 1998) and serves to associate with integrin 
!4 (Rezniczek et al., 1998). The C-terminal region contains  - aside from another 
integrin !4 site (Rezniczek et al., 1998) - the attachment site of intermediate 
filaments (Wiche et al., 1993). More precisely, a basic amino acid region between the 
5th and the 6th plectin repeat is indispensable for the binding of plectin to 
intermediate filaments (Nikolic et al., 1996; Karashima et al., 2012). The interaction 
between these proteins has been the subject of diverse studies (Foisner et al., 1988; 
Hijikata et al., 1999; Favre et al., 2011), indicating a significant role of plectin in the 
architecture of intermediate filament structures (Wiche and Winter, 2011). Other 
binding partners of plectin include vimentin, desmin, fodrin and lamin B (reviewed 
in (Steinböck and Wiche, 1999)), just to name a few. The central coiled-coil domain is 
suggested to be involved in the oligomerisation of plectin. By itself, the coiled-coil 
domain is capable of forming dimers as well as higher oligomeric structures via 
lateral interaction along the coiled coil (Walko et al., 2011).  
Interestingly, plectin exists as multiple isoforms generated by alternative splicing 
(Elliott et al., 1997). Analysing the exon-intron arrangement of human plectin 
revealed that 30 of the 32 exons are located in the N-terminal part of plectin (Liu et 
coiled-coil
Full length Mm Plectin domain organization
plectin-repeatsplakin-domainABD
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al., 1996). Consequently, the different isoforms vary in short sequences in the amino-
terminal domain with the remaining polypeptide being unchanged (Rezniczek et al., 
2003; Wiche and Winter, 2011). This is one of the reasons for the wide range of 
various binding partners of plectin. Subsequently, tissue-dependent variations in the 
expression of plectin isoforms enable different cytoskeleton architectures in reliance 
on the cell’s specific requirements. Interestingly, a rod-less splice variant of plectin 
has been detected in rat (Elliott et al., 1997) and human (Brown et al., 2001). 
Plectin can be found in a variety of different tissues throughout mammalian species 
(Wiche, 1989). In the basal keratinocytes of the skin plectin is an essential 
component of hemidesmosomes (HD), a structure that attaches keratinocytes to the 
basement membrane zone (Tsuruta et al., 2011). Plectin is required for the 
connection of intermediate filaments with integrin (Borradori and Sonnenberg, 
1999). Interestingly, in mouse keratinocytes isoform plectin 1a is selectively 
associated with HDs, while other isoforms are located at the cell periphery (Andrä et 
al., 2003). In the striated muscle cells plectin is situated at the z-discs (Wiche et al., 
1983), the sarcomer boundaries and anchoring points for different filaments (Clark et 
al., 2002). Recent studies further indicate an association of plectin with proteins 
involved in signalling pathways (Lunter and Wiche, 2002; Osmanagic-Myers and 
Wiche, 2004; Gregor et al., 2006), implying a scaffolding role of plectin in these 
processes. 
The large molecular weight of plectin has made it a challenging protein for structural 
studies. Hence, investigations have mainly focused on the analysis of fragments 
rather than the full-length protein. To date, crystal structures of plectin include parts 
of the plakin domain (Sonnenberg et al., 2007; Ortega et al., 2011) and the actin-
binding domain (ABD) of mouse (Urbanikova et al., 2002; Sevcik et al., 2004) and 
human plectin (Garcia-Alvarez et al., 2003). Also, the ABD of human plectin binding 
to a fragment of integrin !4 has been crystallised (de Pereda et al., 2009). However, 
no structural data is yet available for either the coiled-coil rod domain or the C-
terminal globular domain.  
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3.3  Epidermolysis bullosa 
Epidermolysis bullosa (EB) is a skin disorder characterised by blistering of the skin 
and mucus membranes (Shinkuma et al., 2011).  Mutations in genes associated with 
the integrity of the dermal-epidermal basement membrane zone (BMZ) are 
connected to the onset of EB (Pfendner et al., 2005). In general, EB can be 
subdivided into three categories: EB simplex (EBS), junctional EB (JEB) and 
dystrophic EB (DEB) (Uitto and Richard, 2004).  
Mutations in the plectin gene are linked to different forms of EBS, such as EBS with 
muscular dystrophy (EBS-MD) (Chavanas et al., 1996; Gache et al., 1996) and EBS 
with pyloric atresia (EBS-PA) (Pfendner and Uitto, 2005). Both EBS-MD and EBS-PA 
are autosomal recessive, like most of the plectin mutations related to EBS. 
Interestingly, most of the genetic modifications of plectin in EBS-MD result in 
truncated versions of the polypeptide (Pfendner et al., 2005).  
A rare mutation of plectin results in an autosomal dominant form termed EBS-Ogna 
(Koss-Harnes et al., 2002; Walko et al., 2011). It is characterised by a change of 
cytosine (C) to thymine (T) in the central rod region at cDNA position 5998, leading 
to a substitution of arginine (R) for tryptophan (W) in the translated polypeptide 
(Koss-Harnes et al., 2002). Patients suffering from EBS-Ogna show the typical skin 
fragility but no muscular pathologies (Koss-Harnes et al., 2002), indicating that the 
mutation only influences plectin’s function in the skin but not in muscle tissues. This 
is supported by data showing a reduced number of HDs in EBS-Ogna mouse and the 
degradation of plectin 1a (Walko et al., 2011). A current model proposed by Walko 
and colleagues (Walko et al., 2011) suggests that the R2000W mutation in human 
plectin introduces a local instability of the dimeric coiled-coil region, thus facilitating 
the proteolytic degradation of the protein. 
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4 Aim 
The association of mutations in plectin with the disorder epidermolysis bullosa 
underlines the immense importance of the functionality of this cytolinker protein. 
The sub-group EBS-Ogna is characterised by a single amino acid change in the 
coiled-coil region of the protein. This change from arginine to tryptophan (R!W) has 
a drastic effect on the protein’s function and its role in the hemidesmosomes of the 
skin. To unravel the influence of this amino acid change and how this could lead to 
the detrimental effects observed in patients suffering from EBS-Ogna, I will study the 
three-dimensional architecture of the coiled-coil domain of M. musculus plectin. 
More precisely, since the full-length construct is too large to be likely to crystallise, I 
will investigate the structure of smaller parts of the coiled-coil rod containing the 
mutation. The wild-type variant as well as the R!W mutated protein will both be 
studied by protein crystallography. Biochemical studies on the behaviour of the 
recombinant polypeptide will further give a more complete picture of the influence of 
the mutation on the functionality of plectin. 
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5 Materials and Methods 
5.1 Cloning 
General cloning procedures were performed as previously described (part I, chapter 
5.1), unless otherwise stated. 
All wild-type and R1999W (Ogna) plectin 1c rod-constructs in pET15b were obtained 
from Karin Gross (Wiche lab, MFPL, Vienna). Exceptions are the mini-rod constructs 
(wt & Ogna), all mutations listed in Table 4, and the pET29a and MalpET constructs. 
All constructs are summarised in Table 4. The constructs for insect cell expression 
are listed in Table 5 and were cloned and expressed by Karin Gross and Irmgard 
Fischer (Wiche lab, MFPL, Vienna).  
The construct Glob-FL-rod (Table 5) contains the last helix of the 5th spectrin repeat 
and the four spectrin repeats (spectrin repeat 6-9) preceding the coiled-coil domain. 
Single amino acid mutations were introduced using the Pfu-Ultra polymerase (Quick 
change mutagenesis, Stratagene) or Phusion polymerase (New England Biolabs). 
Primers were designed according to the Quick-change mutagenesis protocol 
(Stratagene). To ensure successful amplification of the desired mutation, 18 cycles 
were run. Afterwards, supercoiled template was digested by DpnI for 2 hours at 37°C 
prior to transformation into E. coli DH5". The correct mutation was verified via 
sequencing. 
 79 
Table 4 Constructs for bacterial expression.  
$ Mutations for EPR measurement 
# Mutations for phasing in crystal structure determination 
 
 Name AA range Mutation Vector Affinity tag 
Full-length 
rod 1376-2501 
K2043C$ pET15b/AmpR 6xHis 
 pET15b/AmpR 6xHis N-rod 1375-1806 
 pET29a/KanR no tag 
C-rod 2193-2501 E2367C$ pET15b/AmpR 6xHis 
M-rod 1808-2189 
K1883C$ 
K2043C$  
E2149C$ 
pET15b/AmpR 6xHis 
V2032M# 
L2040M# 
K2043C$ 
L2050M# 
S2058M# 
pET15b/AmpR 6xHis 
Plectin  
mini-rod 1975-2081 
- MalpET/KanR MBP 
      
Full-length 
rod 1376-2501 
K2043C$ pET15b/AmpR 6xHis 
 pET15b/AmpR 6xHis; N-rod 1375-1806 
 pET29a/KanR no tag 
C-rod 2193-2501 E2367C$ pET15b/AmpR 6xHis 
M-rod 1808-2189 
K1883C$ 
K2043C$  
E2149C$ 
pET15b/AmpR 6xHis 
V2032M# 
L2040M# 
K2043C$ 
L2050M# 
S2058M# 
pET15b/AmpR 6xHis 
Ogna  
mini-rod 1975-2081 
- MalpET/KanR MBP 
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Table 5 Constructs for baculovirus/insect cell expression  
 
 
 
 
$ Mutations for EPR measurement 
% These constructs contain the four preceding globular spectrin repeats  
 
5.2 Expression & Purification 
E. coli strain BL21 (DE3) was used for the expression of recombinant proteins. All 
expressions were carried out at low temperature (16° to 18° Celsius) to increase the 
amount of soluble proteins. For a detailed description see part I, chapter 5.2. 
Pelleted cells were resuspended in lysis buffer (20 mM Tris-HCl, pH 8.0, 300 mM 
NaCl, 5% glycerol, 20 mM imidazole, 1 mM PMSF, 2 $g/ml DNAse I) and broken 
using the Emulsiflex-C3 Homogenizer (Avestin). Cell lysate was cleared as described 
in part I, chapter 5.2. Nickel-affinity chromatography was taken as the first 
purification step, using a gravity column or a HiTrap chelating HP column (GE 
healthcare) on a Äkta purifier (GE healthcare). Bound proteins were eluted via an 
increasing imidazole gradient. If the protein was used for crystallographic studies, the 
N-terminal 6"His tag was removed via thrombin digestion (20% of total protein 
amount) overnight at 4°C. The affinity-purified protein was concentrated using 
Amicon ultra centrifugal filters (MWCO: 3 - 50kDa) and subsequently loaded on a 
size exclusion chromatography column Superdex-200, 16/60 or the analytical 
Superose 6 10/300 (HiLoad; GE healthcare), which was pre-equilibrated with SEC-
buffer 1 (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 5% glycerol) or SEC-buffer 2 (20 
mM HEPES, pH 7.5, 100 mM NaCl, 5% glycerol). In general SEC-buffer 1 was used. 
SEC-buffer 2 was used only if subsequent biochemical analysis was incompatible with 
a Tris-HCl-based buffer. 
 
 Name AA range Mutation Affinity tag 
Full-length rod 1376-2501 K2043C$ 6xHis 
Plectin  
Glob-FL-rod%  898-2501  6xHis; 
Full-length rod 1376-2501 K2043C$ 6xHis 
Ogna  
Glob-FL-rod%   898-2501  6xHis; 
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5.2.1 Purification of protein produced in insect cells 
Insect cell pellets containing the constructs listed in Table 5 were obtained from 
Wiche’s lab (MFPL, Vienna). The pellets were lysed in buffer A (20 mM HEPES, pH 
7.4, 1% glycerol, 1% Triton X-100) prior to centrifugation at 16.000 rcf for 30 minutes 
at 4°C. The supernatant was diluted 6 times with HiTrap buffer (50 mM sodium 
phosphate pH 7.4, 300 mM NaCl) and loaded on a 1-ml HiTrap chelating HP column 
(GE Healthcare) charged with Co2+. The bound protein was eluted via a linear 
imidazole gradient. The protein was either directly used for rotary metal shadowing 
experiments or dialysed against HiTrap buffer to remove the imidazole.  
 
5.3 Selenomethionine labelling 
To express selenomethionine-labelled protein, the methionine auxotrophe strain E. 
coli B834 was used (gift from the Clausen lab, IMP, Vienna). Cells from 10 ml of 
overnight cultures were pelleted and resuspended in 1L of minimal media (60 mM 
K2HPO4, 33 mM KH2PO4, 7.5 mM (NH4)2SO4 and 1.7 mM Tri-Sodium Citrate), 
supplemented with 1 mM MgSO4, 0.00048% Thiamine, 40 µg/ml amino acid mix 1 
(Table 6), 40 µg/ml amino acid mix 2 (Table 6), 40 µg/ml selenomethionine and 
0.2% glucose. When OD600 reached 0.5-0.6 at 37°C, cells were immediately chilled on 
ice for 10 minutes and transferred to 18°C. 30-45 minutes after this transfer, the 
protein expression was induced by 0.5 mM IPTG. Cells were harvested 18-20 hours 
post induction. Selenomethionine-labelled protein was purified in the presence of 
either 10 mM !-mercaptoethanol (for affinity purification) or 5 mM DTT (for size-
exclusion chromatography) in all buffers. 
Table 6 Composition of the amino acid mixes. 
Amino acid mix  Ingredients 
1 
all L-amino acids except methionine, tyrosine, tryptophan and 
phenylalanine dissolved in sterile water 
stock concentration: 40 mg/ml 
2 
tyrosine, tryptophan and phenylalanine, dissolved in sterile water, small 
amount of hydrochloric acid was added to improve solubility 
stock concentration: 40 mg/ml 
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5.4 Lysine methylation 
Lysine methylation as described by Walter and colleagues (Walter et al., 2006) was 
used to improve the crystallisation. In short, following procedure was used, all steps 
carried out at 4°C. 
Affinity purified protein was desalted into methylation buffer (50 mM HEPES pH 7.5, 
250 mM NaCl) via a HiPrep 26/10 desalting column (GE Healthcare) and diluted to a 
concentration of less than 1 mg/ml. For each millilitre of protein solution, 20 µl of 1M 
dimethyl-borane complex (DMBC, Sigma; dissolved in ddH20) and 40 µl of 1M 
formaldehyde (Merck) were added and stirred at 4°C for two hours, followed by 
another addition of 20 µl 1M DMBC and 40 µl 1M formaldehyde. After incubation for 
two more hours, a final amount of 10 µl 1M DMBC was added. The protein solution 
was continuously stirred at 4° over night. On the next day precipitated protein was 
removed by centrifugation, followed by size-exclusion chromatography using SEC 
buffer 1. Methylated protein was concentrated to a final concentration of 5-20 mg/ml 
and utilised for crystallisation trials.  
 
5.5 Static light scattering 
All static light scattering (SLS) experiments were carried out on an instrument from 
Wyatt Technology Corp. The system consists of a HPLC system (Agilent 
Technologies) that is connected in sequence to a triple-angle laser light scattering 
detector (miniDAWN TREOS), a UV detector (280nm, Agilent Technologies) and a 
refractive index detector (RI-101, Shodex). 100 µg of the respective protein was 
loaded on a Superose 6 10/300 column (GE healthcare) or Superdex 200 10/300 (GE 
healthcare) pre-equilibrated with SLS buffer (20 mM Tris-HCl pH 8.0, 100 mM 
NaCl) and eluted at a constant flow rate of 0.5 ml/min. The collected data was 
analysed with the Astra software (Wyatt technology). 
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5.6 Chemical cross-linking 
Glutaraldehyde cross-linking was performed as described in part I, chapter 5.3. 
Alternatively, dimethyl-pipelimidate (DMP, Sigma) was used for chemical cross-
linking. DMP has an arm-length of 9.2 Å. Prior to cross-linking, the protein was 
transferred into cross-linking buffer 1 (20 mM HEPES, pH 7.5, 100 mM NaCl, 5% 
glycerol) or cross-linking buffer 2 (50 mM Bicine, pH 8.5, 27.5 mM NaCl, 26 mM 
KCl) either by size-exclusion chromatography or micro-Biospin columns P-6 (Biorad) 
and diluted to 0.5-1 mg/ml. 
DMP was mixed with the protein of interest at a final concentration of 20 mM DMP 
and allowed to react for 30-40 minutes at room temperature. The reaction was 
stopped by the addition of 100 mM Tris-HCl (pH 8.0). The cross-linking results were 
analysed by SDS-page. 
 
5.7 Electron microscopy  
All electron microscopy experiments were carried out with the help of Ekaterina 
Shimanovskaya (negative staining and image acquisition) or Marlene Brandstetter 
(rotary metal shadowing and image acquisition).  
For all negative staining experiments, protein at a concentration of approximately 60 
µg/ml was adsorbed to glow-discharged grids and stained for 1 minute using 2% 
uranyl acetate with unadjusted pH. 
For rotary metal shadowing, protein at a concentration of approximately 25 µg/ml in 
buffer containing 20% glycerol (v/v) was prepared. The samples were rotary 
shadowed with 0.7 nm platinum/carbon at an angle of 5 degree.  
Image acquisition was done on a Morgagni 268D electron microscope (FEI) at 80 kV. 
Image analysis was done using ImageJ (http://rsbweb.nih.gov/ij/). 
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5.8 Electron Paramagnetic Resonance Studies 
To determine the coiled-coil orientation, electron paramagnetic resonance (EPR) 
spectroscopy of site-directed spin labelled constructs was carried out. This method 
enables to study the conformation of a target protein by introducing a paramagnetic 
spin label into the macromolecule. The spin label is attached to accessible cystein 
residues in the protein and subsequent spectroscopic measurements can yield 
information about the distance of other paramagnetic labels in the protein within a 
distance of 1-8 nm (Steinhoff, 2002). The orientation of coiled-coil systems can be 
determined by either pulsed EPR measurements for distances in the range of 2-8 nm 
or low-temperature continuous wave (cw)-EPR measurements for short distances 
(below 2 nm). All EPR measurements as well as subsequent data analyses were 
carried out under supervision of Dr. Katharina Pirker (AIT Tulln). 
To attach the paramagnetic spin label the following procedure was used: 
Purified protein in SEC buffer 1 (20 mM Tris-HCl pH 8.0, 100 mM NaCl, 5% glycerol) 
or affinity chromatography buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 5% 
glycerol, 250-400mM imidazole) was incubated with the spin label (1-Oxyl-2,2,5,5-
tetramethyl-!3-pyrroline-3-methyl) Methanethiosulfonate (MTSSL, Toronto 
Research) at a ratio of 1:8 or 1:20  (protein : MTSSL) and kept rotating at 4°C in the 
dark over night. Excess of unbound spin label was removed using a PD-10 desalting 
column (GE healthcare) followed by size-exclusion chromatography (Superdex 200 
16/60, GE healthcare). The labelled protein was concentrated to at least 50 µM for 
subsequent measurements. 
Initial cw-EPR spectra were collected at UFT Tulln on a Bruker EMX spectrometer 
operating at 9.4 GHz equipped with a high sensitivity resonator. Low temperature 
measurements were carried out using a variable temperature unit cooled with liquid 
nitrogen. All room temperature measurements were carried out with 1 mW 
microwave power, 100 kHz modulation frequency, 0.1 mT modulation amplitude and 
41 ms conversion time and time constant. Parameters for 160 K measurements were 
chosen with 0.2 mW microwave power, 100 kHz modulation frequency, 0.25 mT 
modulation amplitude and 41 ms conversion time and time constant. 
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Samples with spin label efficiency of higher than 60% were taken for double electron-
electron resonance (DEER) measurements at Bruker BioSpin Headquarters 
(Rheinstetten, Germany). DEER experiments were performed at 60 K on a Bruker 
ELEXSYS spectrometer operating at 9 GHz. The four-pulse DEER sequence was 
chosen with !/2("obs)-#1-!("obs)-t’- !("pump)-(#1+#2-t’)-!("obs)-#2-echo, where the 
observer pulse length was 12 ns for !/2 and 24 ns for ! pulses. The pump pulse length 
was 12 ns, the long interpulse delay was #2 = 1200, 2000 or 3000 ns. All other 
parameters were used according to (Pannier et al., 2000). The DEER spectra were 
analysed using the programme DeerAnalysis2010 (Jeschke, 2006). The background 
was corrected by a homology 3-dimensional fit. Simulations were checked for 
stability according to the DEERAnalysis2010 manual. 
To determine distances shorter than 2 nm, low-temperature cw-EPR was used. A spin 
dilution experiment as described in Gross et al (Gross et al., 1999) was carried out in 
order to prepare control samples for the parallel as well as anti-parallel coiled-coil 
constructs. In the control, only one fifth of every spin label site is occupied by the 
paramagnetic label, whereas the other ones sites carry a diamagnetic analogue. A 1:4 
mixture of MTSSL and a diamagnetic analogue (1-Acetyl-2,2,5,5-tetramethyl-!3-
pyrroline-3-methyl Methane-thiosulfonate (MTS), Toronto Research) was prepared 
and added with an 8 times molar excess to the affinity purified protein. Following 
overnight incubation at 4°C, excess spin label was removed as described above for the 
regular labelled samples. Spectra were collected at 160 K. Analysis of the spectra 
broadening and computation of the short distance were done with the programme 
WinDipfit (Steinhoff et al., 1997). 
!
5.9 Crystallisation & data collection 
Initial protein crystallisation trials were pipetted using a Phoenix/RE robot (Art 
Robot Industries) for sitting drop vapour diffusion. Either Intelli-3-well plates (Art 
Robot Industries) or MSC-2-well plates (Swissci) were used in combination with 
different commercially available screens (Table 7) to identify suitable crystallisation 
conditions. Plates were stored at either 22°C or 4°C in a crystallisation hotel 
CrystalMation (Rigaku). 
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Table 7 Commercial crystallisation screens tested. 
Company Screen 
Hampton Research Crystal screen I & II 
 Cryo 1-2 
 PEG/ion 
 Additive screen 
 Detergent screen 
Emerald Bioscience Wizard I & II 
Molecular Dimension Morpheus 
 Midas 
 PACT premier  
Jena Bioscience JBS 1-4 
Initial crystallisation hits were manually optimised by using hanging drop vapour 
diffusion in 48-well plates (VDX48, Hampton Research). Optimised crystals were 
tested in-house on an X8 PROTEUM (BrukerAXS). To avoid damage during freezing, 
crystals were equilibrated in cryo-protectant solution prior to freezing in liquid 
nitrogen. Cryo-protection was achieved by adding either 20% glycerol or 40% 
PEG400 to the given crystallisation condition.  
For improvement of diffraction data, crystal dehydration technique (Heras et al., 
2003) was applied. Following two approaches were tested. Crystals were transferred 
to 3 µl of cryo-protectant solution (crystallisation solution + cryoprotectant) and 
equilibrated overnight against 400 µl of dehydration solution (crystallisation solution 
+ 40% PEG 400). Alternatively, crystals were moved to 15 µl dehydration solution 
and equilibrated against air for approximately 2 hours, prior to freezing in liquid 
nitrogen.  
Crystal diffraction data was collected at the European Synchotron Radiation Facility 
(ESRF) in Grenoble, France. The native crystal dataset was collected at ID23-1 and 
the selenomethionine crystals at the tuneable beamline ID14-4. The collected 
diffraction data were integrated using iMosflm (Battye et al., 2011) and scaled using 
the SCALA software (Evans, 2006). Autosol, part of the software suite Phenix 
(Terwilliger et al., 2009), was used to locate the selenium sites and to calculate the 
experimental maps. The model was built in COOT (Emsley and Cowtan, 2004) and 
refinement was done using CNS (Brunger et al., 1998). 
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6 Results 
EBS-Ogna is caused by a single amino acid replacement at position 2000 (R2000W) 
in human and position 1999 (R1999W) in mouse plectin. It represents a unique 
plectin mutant that results in this rare autosomal dominant disorder. To investigate 
the structural basis of this mutant, a number of constructs of the coiled-coil domain 
of mouse plectin 1c (Refseq NM_011117.2) have been generated for crystallographic 
and biochemical studies (Figure 19). The three constructs spanning residues 1376-
2501 (full-length), 1808-2189 (M-rod) and 1975-2081 (mini-rod), which all contain 
the mutation position, have been cloned both as wild-type (wt) and as mutant 
(R1999W; Ogna) form. 
 
Figure 19 Constructs and expression of the plectin coiled-coil rod. (a) Full-length (FL) coiled coil of 
plectin was analysed by the COILS server. (b) A schematic representation of several generated constructs. The 
mutation R1999W is indicated relative to its position in the given construct. Simplified names of the constructs 
are given in italic. (c-e) Purification of different truncations of recombinant plectin after overexpression in E. coli. 
The black arrows mark the proteins of interest; the red arrow marks degraded proteins. 
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The full-length coiled-coil construct (residues 1376-2501), which has a theoretical 
molecular weight of 130 kDa, showed on an SDS-PAGE a band of ~150 kDa (Figure 
19e, black arrow). Aside from the aberrant migration behaviour during 
electrophoresis, part of the protein degraded readily into a stable 50 kDa fragment 
(Figure 19e, red arrow).  The N-terminal 6"His tag was removed via thrombin 
digestion. SDS-Page analysis revealed that the 50-kDa degradation product was also 
digested by thrombin (data not shown), indicating that it is a degraded product from 
the C-terminus of the full-length rod. Other generated coiled-coil constructs could be 
purified with only minor impurities and were used for structural studies (Figure 19c, 
d; black arrows indicate the protein of interest). 
 
6.1 Oligomerisation state of the plectin coiled-coil rod 
Because of the aberrant elution behaviour due to the elongated shape, size-exclusion 
chromatography is not suitable for the determination of the molecular 
weight/oligomerisation of a coiled-coil protein. Static light scattering (SLS) is an 
alternative approach that is able to measure the molecular weight of a molecule 
independent of its shape. Thus, SLS was used to examine the oligomerisation state of 
the recombinant plectin coiled-coil rod in addition to chemical cross-linking 
experiments. All of the generated constructs (Figure 19b) were used for this study. 
The recombinant proteins were purified by Ni-NTA affinity chromatography and 
subsequently used for SLS measurements. It has been shown previously that the full-
length rod expressed in insect cells forms both dimers and higher oligomers in 
solution (Walko et al., 2011).  
SLS results indicated that the full-length rod produced in bacteria has a molecular 
weight of 150 kDa for both wt and Ogna (Figure 20a). This is only slightly larger than 
the theoretical weight of 130 kDa of the monomer protein, indicating that this 
construct is a monomer. Aside from the monomeric peak, two lower molecular weight 
peaks were detected (Figure 20a). They most likely contain degradation products of 
the full-length rod, since the protein is not stable in solution (Figure 19e, red arrow). 
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Figure 20 Static light scattering (SLS) analyses of different truncations of the plectin rod domain. 
(a) Full-length rod was calculated to be ~15o kDa in solution, corresponding to a monomer. (b) The molecular 
weight of the M-rod slightly differed between wild-type and Ogna. (c) The mini-rod of plectin showed a molecular 
weight of 13kDa, corresponding to a monomer. (d) SLS showed that the C-terminal rod forms a trimer and a 
dimer. An aggregation peak is eluting at 8ml. (e) Plectin N-rod was calculated to be a monomer. (f) Cross-linking 
results of different truncations. 0.01% glutaraldehyde was used to cross-link plectin N-rod and C-rod for 5 
minutes and plectin M-rod (wt/Ogna) for 10 minutes at room temperature. DMP was used to cross-link both wild-
type and Ogna mini-rod. 
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SLS results also indicated that the M-rod has a molecular weight of approximately 90 
kDa for wild-type plectin, suggesting a dimeric form. Interestingly, however, the 
Ogna mutant of the same segment was measured to be about 70 kDa (Figure 20b).  
This does not match either the monomeric form (45 kDa) or the dimeric form (90 
kDa). A possible explanation is that there is an intermediate state between monomer 
and dimer and the averaging algorithm of the program is not able to reflect such a 
state. Using glutaraldehyde to cross-link the species present in wild-type and Ogna 
plectin M-rod, bands corresponding to both a dimer and a tetramer were observed 
(Figure 20f). 
The two mini-rod constructs (residues 1975-2081) were also analysed by SLS. 
Surprisingly, the molecular weight for both wild-type and the Ogna mutation was 
measured to be 12-13 kDa, a clear monomer (Figure 20c), while chemical cross-
linking using dimethyl pipelimidate (DMP) showed dimerised protein bands (Figure 
20f).  
Analysing the C-rod by chemical cross-linking showed that the protein is 
predominantly a dimer in solution (Figure 20f). By SLS, the construct was found to 
be a dimer; additionally a peak corresponding to a trimer could also be observed 
(Figure 20d). Interestingly, the N-terminal region of the rod was found to be a 
monomer both by SLS and glutaraldehyde cross-linking (Figure 20e, f).  
To test whether the N-rod and C-rod are able to interact – as they would in an anti-
parallel coiled-coil conformation – both purified proteins were mixed and loaded on 
a Superdex 200 10/300 (Figure 21a).  For comparison, the individual constructs were 
also loaded on the same size-exclusion column (Figure 21b, c). Plectin N- rod alone 
eluted around ~12.8 ml (Figure 21b); the C-terminal rod eluted both at the void 
volume and at 11.6-13 ml (Figure 21a, c). The size-exclusion chromatogram of the 
mixed N- and C-rod showed plectin N-rod to still elute at approximately 12.7 ml, and 
plectin C-rod to elute in the same range as in the individual run (Figure 21a). No 
higher molecular weight peak corresponding to a complex between N- and C- rod was 
observed.  
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Figure 21 Interaction test of the N- and C-termini of the plectin coiled coil. (a) The purified N- and C-
terminal part of the coiled-coil rod were mixed in an equimolar ratio and loaded on an analytical Superdex 200 
10/300 column. (b, c) The individual constructs were loaded on the same column for comparison. (b) Plectin N-
rod eluted at ~12.8 ml. (c) The C-rod construct eluted at the void volume and between 11.6-13 ml. This fragment 
does not contain any tryptophan, thus the UV at 230 nm was measured. (d) Affinity purification of the co-
expressed plectin untagged N-rod and 6"His-tagged C-rod. FT, flowthrough.  
Furthermore, 6"His-tagged plectin C-rod was unable to capture untagged plectin N-
rod in significant amounts upon co-expression (Figure 21d).  
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These results suggest that the N- and C-terminal part of the coiled coil do not 
interact, thus it is likely the plectin coiled coil has a parallel arrangement in a dimeric 
form. 
 
6.2 Influence of the R1999W mutation on the oligomerisation 
of the full-length rod 
During affinity purification and SLS measurements, no significant differences 
between wild-type and Ogna plectin were observed. To investigate how this mutation 
may influence the integrity of the protein, I used analytical size-exclusion 
chromatography to study differences in the oligomerisation ability of the full-length 
plectin rod in both wild-type and Ogna forms. Since the UV signal did not correspond 
to the amount of protein loaded on the SDS-PAGE, the band intensities on the SDS-
PAGE were analysed using ImageJ (http://rsbweb.nih.gov/ij/) to plot against the 
fraction number (Figure 22). 
 Comparison of both plectin and Ogna full-length rod showed that they peaked at 
different elution volumes (Figure 22c). While wt plectin tended to form oligomers to a 
large extent, the mutant counterpart existed almost equally as oligomers and dimers. 
Therefore, the mutation seems to impair the protein’s ability to form larger 
oligomers. One possibility is that the residue R1999 contributes to the oligomeric 
association of the rod domain; substituting it by the bulky and hydrophobic aromatic 
tryptophan (W) might weaken this association. The same analysis of the wild-type 
and the Ogna mutant of the M-rod indicated a similar pattern (data not shown). 
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Figure 22 Analytical gel-filtration analyses of wt and the Ogna mutant of the plectin rod domain. 
Full-length rod samples pre-purified by Ni-NTA were loaded on the Superose 6 (10/300) column. 1 ml each for 
fractions from the void volume (fraction ‘A1’) onwards were collected and analysed on an SDS-PAGE. Band 
intensities were computed using ImageJ. (a) Elution profile of the wild-type plectin rod domain. (b) Elution 
profile of the Ogna mutant of the plectin rod domain. (c) The curves of both wild-type and mutated plectin were 
overlaid for comparison. 
 
6.3 Crystallisation of Ogna mini-rod 
The shortest construct Ogna mini-rod was successfully crystallised in 0.1 M 
sodium/potassium phosphate pH 6.2, and 2-2.5 M sodium chloride.  
A native dataset was initially collected to 2.5 Å resolution, but spots with rotational 
disorder were observed (Figure 23a). To solve the phase problem, single wavelength 
anomalous dispersion (SAD) was utilised, using selenomethionine labelled protein. 
Initial attempts to solve the phase were not successful because the selenomethionine 
sites could not be found. This was later explained by the observation that the first 12 
residues containing the selenomethionine labelled residues are disordered in the final 
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structure (Figure 23c). Therefore, we have generated the following mutations in the 
central region of the protein: V2032M, L2040M, L2050M and S2058M  (Figure 23c). 
Each single mutant was expressed and used for crystallisation. 
 
Figure 23 Crystallisation and structure determination of the Ogna mini-rod.  (a) Diffraction pattern 
of the native crystal. The red square shows an amplification of an area for a better view of the smearing spots. (b) 
Diffraction pattern of the crystals after lysine methylation. The red square shows the discrete spots without 
rotational disorder. (c) Amino acid sequence of the Ogna mini-rod. In italic grey are the residues that are missing 
in the final structure. The yellow methionine is the only native methionine in the mini-rod construct. It could not 
be detected in the initial SAD phasing due to the disordered N-terminal 12 residues in the final structure. The red 
arrows mark the residues that were mutated to methionine for phase determination. (d) Crystals of the L2050M 
mutant. (e) The experimental electron density map of the anti-parallel Ogna mini-rod. In red are the two 
selenomethionine groups in the dimer. 
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No crystals were obtained for S2058M, whereas V2032M only produced small 
crystals. L2040M and L2050M both crystallised in sodium/potassium phosphate pH 
6.0, 5 mM DTT and 2.5 M sodium chloride (Figure 23d). Both selenomethionine 
constructs diffracted well and data collected from Ogna L2050M was used for SAD-
phasing. However, although it was possible to solve the phase problem this time and 
an anti-parallel coiled coil could be built (Figure 23e), the model could not be refined 
to a satisfactory statistics (Rwork ~40%). This was later found to be due to the 
observed rotational disorder of the native dataset (Figure 23a), which left significant 
residual electron densities around the two continuous helices unassigned. 
Table 8 Data collection and refinement statistics. 
Data collection  
Space group 
I422 
Cell dimensions  
 a, b, c (Å) 105.59, 105.59, 90.40 
Resolution (Å) 35-3.5 (3.83-3.50) * 
No. unique reflections 31475 (3397) 
Rsym 
I / sI 
0.212(0.883) 
8.7 (3.5) 
Completeness (%) 99.9 (100.0) 
Redundancy 9.3 (9.7) 
 
Refinement 
 
Resolution (Å) 
35-3.5 
Rwork / Rfree (%) 27.2/30.2 
No. atoms  
    Protein 720 
R.m.s. deviations  
   Bond lengths (Å) 0.0106 
Bond angles (°) 1.33 
*Values in parentheses are for highest-resolution shell. 
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Figure 24 Crystal structure of the Ogna mini-rod. (a) Ribbon diagram of the refined model. The anti-
parallel coiled-coil rod has a length of 13 nm. (b) Enlargement of the rectangular area in (a). The mutation of 
R!W is at the terminal part of the coiled coil, with the tryptophan side-chain pointing outwards.  (c) Symmetry-
related molecules in the crystal lattice. (d) The tryptophan residue W1999 is involved in crystal contacts with 
neighbouring molecules in the crystal lattice.  
To resolve the packing disorder of the crystal, the Ogna mini-rod was re-purified and 
subjected to lysine methylation, which alters surface charges of a target protein and 
may change the crystal packing. Ogna mini-rod contains 6 lysines that were modified 
by the method as described in Materials & Methods (chapter 5.4). The methylated 
protein crystallised in 0.1 M sodium acetate pH 4, 20% PEG 400 and 0.1 M CaCl2 (or 
0.1 M MgCl2). Diffraction data was collected to 3.3 Å resolution (Figure 23b). To 
further improve the diffraction data, crystal dehydration was tested, which has been 
shown to be effective in obtaining a better resolution (Heras et al., 2003). The 
dehydrated protein crystals did not show an improved diffraction data. The final 
structure was obtained with a resolution of 3.3 Å (Figure 24a). The protein 
crystallised in space group I422. The summary of the data collection and the 
refinement statistics are shown in Table 8. 
The short coiled-coil rod is a dimer oriented in an anti-parallel manner. The first 
twelve amino acids at the N-terminus and the last eight residues at the C-terminus 
are missing in the final structure. The mutation R1999W is located close to the N-
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terminus of each strand (Figure 24b). Closer examination revealed that W1999 is 
involved in crystal contacts within the crystal lattice (Figure 24c), which explains why 
the wt form of the same construct could not be crystallised under the same condition. 
Figure 25 shows the crystal packing of the dimeric protein from the three different 
axes.  
 
Figure 25 Crystal packing of the Ogna mini-rod. The arrangement of the Ogna mini-rod dimers in the 
crystal lattice is shown by looking down the (a) a-axis, (b) b-axis, and (c) c-axis. (d) The same view as (c) with all 
side chains shown. The crystal has a solvent content of 75%. The central yellow squares in the figures mark the 
unit cell. 
Although the SLS results of plectin mini-rod suggest the protein to be a monomer in 
solution (Figure 20c), in the crystal it is clearly a dimer. It is likely that the protein is 
not completely in a dimerised state in solution, but crystallisation favoured the 
dimerised protein.  
To compare the Ogna structure with wild-type plectin, I also attempted to crystallise 
wt-plectin mini-rod but did not succeed in obtaining good crystals. The protein 
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crystallised in only small needle-like clusters, which were unsuitable for data 
collection. Further optimisations including streak- or micro-seeding were not 
successful in obtaining single, diffracting crystals. It is likely that the replacement of 
arginine by tryptophan, which contributes to crystal contacts in the Ogna mini-rod 
(Figure 24c, d), is critical in obtaining well ordered packing of the molecules in a 
crystal. Attempts to crystallise larger parts of the coiled-coil rod were also 
unsuccessful. 
 
6.4 Negative staining electron microscopy studies 
Since it was not possible to obtain a crystal structure for the other coiled-coil 
constructs aside from Ogna mini-rod, electron microscopy (EM) was used to study 
potential structural differences between the wild-type and mutant plectin. MBP-
10"His-tagged plectin M-rod, both wild-type and Ogna, were purified using Ni-NTA 
affinity chromatography and subsequently labelled with 5-nm nano-gold (chapter 
5.7).  
 
Figure 26 Electron microscopic studies of nano-gold labelled plectin. (a) Wild-type MBP-plectin M-rod 
and (b) MBP-Ogna M-rod were labelled using 5-nm nano-gold and stained by uranyl-acetate. The nano-gold label 
is visible as black dot. Scale bars: 50 nm. 
In the case of a parallel arrangement of the coiled coil, both labels should be close to 
each other, whereas in an anti-parallel arrangement the labels should have a distance 
a b
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of 60 nm. Although the nano-gold particles were clearly visible, no consistent 
distribution pattern was observed (Figure 26). 
 
6.5 Electron paramagnetic resonance studies  
To investigate whether there is a difference in the coiled-coil arrangement of the 
wild-type and the Ogna plectin rod domain, electron paramagnetic resonance 
spectroscopy (EPR) was used as an alternative to protein crystallisation and EM 
studies. In short, this technique allows measuring the distance between paramagnetic 
spin labels up to 8 nm in a biological macromolecule. The paramagnetic spin label, 
usually MTSSL (chapter 5.8), is attached via a cysteine-disulfide bridge to the protein 
(Figure 27a).  
 
Figure 27 Principle of EPR spin label attachment. (a) The paramagnetic spin label (MTSSL, in our case) is 
attached to an accessible cysteine residue in the protein of interest. (b) Depending on the orientation of a coiled 
coil, the spin labels can be in distant or close position. EPR allows to measure the distance between the spin labels 
and to allow the identification of the orientation of the coiled coil. 
Due to the lack of cysteine residues in the plectin coiled-coil rod, cysteine had to be 
introduced in order to be able to label the protein. 
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Since full-length recombinant plectin rod domain purified from bacteria easily 
degraded, two shorter coiled-coil constructs were used for this study. Plectin mini- 
and M-rod, both wild-type and Ogna were tested. Based on the crystal structure of 
Ogna mini-rod, a lysine at position 2043 was mutated to cysteine (Figure 28, 
highlighted in brown). Aside from its accessibility, the computed distance between 
the introduced cysteines in the dimer was optimal for the EPR measurements. At this 
position, the distance of the anti-parallel dimer was calculated to be 3.5 nm. In a 
parallel orientation the distance of the spin labels was estimated to be lower than 2 
nm, making both conformations measureable for either pulsed (double electron 
electron resonance - DEER) or low-temperature continuous wave (cw) EPR (Figure 
27b).  
 
 
Figure 28 Illustration of the two K2043 residues on the anti-parallel Ogna mini-rod dimer.  
DEER measurements showed the expected anti-parallel arrangement of Ogna-
K2043C mini-rod with a distance distribution of 3.3 nm (Figure 29a, c). Interestingly, 
plectin-K2043C mini-rod also showed a similar distance of 3.2 nm (Figure 29b, c), 
indicating an anti-parallel arrangement of the coiled coil for both constructs. 
Measuring of the larger construct M-rod revealed that both wild-type plectin and 
Ogna showed no distance larger than 2 nm (Figure 29d, e, f).  
Since 2 nm are at the lower limit of DEER measurements, a different experimental 
setup had to be used to determine the exact distance between labelled sites of M-rod 
constructs. Cw-EPR spectra collected at 160 K are known to broaden due to spin-spin 
dipolar interactions if the spins are in a distance below 2 nm (Steinhoff et al., 1997). 
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Figure 29 DEER measurements of the M- and mini-rod of Ogna and wild-type plectin. Purified 
protein was labelled using the paramagnetic spin label MTSSL and distances were measured by pulsed EPR. (a & 
b) The form factors of (a) wild-type and (b) Ogna mini-rod are shown. (c) The computed distance distribution for 
the mini-rod constructs. (d - f) The results for plectin M-rod are given. Spectra of (d) wild-type and (e) Ogna are 
shown. (a, b, d, e) The red line indicates the fitted curve used to compute the distance. (c & f) The resulting 
distance distribution was calculated for wt (yellow) and Ogna (blue) plectin. 
Using a control sample with only 1 spin-label per dimer (for sample preparation, see 
chapter 5.8), the broadening of the double-labelled sample spectra compared to the 
single-labelled spectra was evaluated and used to determine the distance of the 
interacting spins. Plectin-K2043C mini-rod served as the control sample for the 
measurements. Spectra of the spin labelled proteins and the control sample were 
recorded at 160 K by cw-EPR (Figure 30).  
As expected, no broadening of plectin or Ogna-K2043C mini-rod spectra was 
observed (Figure 30a, b). Both wild-type and Ogna plectin-K2043C M-rod spectra 
showed a clear broadening compared to the control sample (Figure 30c, d). A 
distance of 1.8 nm between the spin labels was calculated. These results showed that 
the crystallised mini-rod is anti-parallel regardless of the R1999W mutation. 
Interestingly, a longer part of the middle coiled-coil segment (M-rod) showed a 
parallel arrangement. Therefore, although different constructs of the rod domain 
showed different orientations of the two strands, the mutation R1999W did not 
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change the conformation within the same region examined in comparison to wild-
type plectin. It can be concluded that the full-length rod domain likely adopts a 
parallel coiled-coil dimer while the crystal structure Ogna mini-rod may represent a 
local anti-parallel interaction. 
 
Figure 30 Low-temperature cw-EPR measurements of the M- and mini-rod of Ogna and wild-type 
plectin. (a - d) Purified protein was labelled with paramagnetic spin label and was measured at 160 K by cw-EPR 
(red spectra). As a control, spectra of spin diluted (single-labelled) protein were collected (black). The broadening 
of the spectra was used to compute the distance between the spin labels. Spectra of wild-type (a, c) and Ogna (b, 
d) for mini- (a, b) and M-rod (c, d) are shown. 
The form factors of all the constructs from the DEER measurements indicated a 
rather low modulation depth. The modulation depth indicates the number of coupled 
spins in the analysed system. In a coiled-coil system the expected number of coupled 
spins would correspond to 2, which was not achieved by any of the samples analysed 
by DEER. Instead, the average number of coupled spins was ~1.2. This suggests that 
the protein, regardless of construct and/or mutation, is not in a complete dimerised 
state and this would also support the SLS results observed for plectin wt/R1999W 
mini-rod (Figure 20c). 
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To further investigate the integrity of the coiled-coil, other amino acid residues were 
mutated and measured by EPR. K1883 and E2149 were separately changed to 
cysteine in plectin M-rod of wild-type and Ogna. Both positions were predicted to be 
at the position b and f of the heptad repeat, thus likely to be accessible for the spin 
label. Low-temperature cw-EPR revealed that for both mutations, K1883C and 
E2149C, no short distance was detected, regardless of plectin or Ogna (data not 
shown). It is possible that the coiled-coil structure at the terminal regions of plectin 
M-rod is opening up to some extent, leading to the absence of any short distance. 
Table 9 Spin label efficiency 
Sample Protein : MTSSL Label efficiency (%) 
Plectin mini-rod 1:8 93.01 
1:8 41.44 Ogna mini-rod 
1:20 90.56 
Plectin M-rod 1:8 88.79 
Ogna M-rod 1:8 65.86 
It is noteworthy that, although the EPR data did not show any difference between 
wild-type and mutant plectin within the respective constructs, higher spin label 
efficiency was observed for plectin in comparison to Ogna throughout all labelling 
experiments (Table 9). 
 
6.6 Rotary metal shadowing EM studies 
Due to the different EPR results observed for plectin/Ogna mini- and M-rod, rotary 
metal shadowing experiments were conducted to assess the orientation of the full-
length coiled-coil rod of wild-type plectin. A construct spanning residues 898-2501 of 
plectin was used for this purpose. This construct contains the C-terminal 478 amino 
acids of the plakin domain (i.e. the last four spectrin repeats) preceding the plectin 
coiled-coil domain (Figure 31a) and was expressed in the baculovirus/insect cell 
system (see part II, section 5.2.1, Table 5).  
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Figure 31 Rotary metal shadowing EM micrographs of the full-length plectin coiled coil with the 
preceding spectrin repeats. (a) A schematic representation of the plectin construct used for rotary metal 
shadowing. A fragment of the plakin domain and the coiled-coil domain were expressed in insect cells. (b) Rotary 
metal shadowing EM micrographs. The images repeatedly show the same structure containing a “head” (blue 
arrowhead) and a 135 – 190 nm long “tail”. Scale bar: 200 nm. (c) A schematic representation of the potential 
arrangements of the used construct. 
The linear coiled-coil domain can be clearly seen on various positions on the grid 
(Figure 31b). Length measurements showed that the coiled coils are between 140 and 
190 nm long, with the majority being approximately 180 nm long. This is going in 
line with the theoretical length of 170 nm for the fully extended coiled-coil domain. 
Interestingly, the four spectrin repeats in front of the coiled-coil were consistently 
observed on only one end of the rod domain (Figure 31b, blue arrowhead). This 
suggests a parallel arrangement of the full-length plectin coiled coil (Figure 31b). 
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7 Discussion 
Plectin - as a versatile cytolinker - is of crucial importance in the maintenance of the 
cytoskeleton integrity (Andrä et al., 1998), (Hijikata et al., 1999). Along with other 
proteins, plectin is a constitutive component of hemidesmosomes and dysfunctions of 
these proteins have been linked to the disease epidermolysis bullosa (EB) (Uitto and 
Richard, 2004). Among the more than 30 mutations identified in plectin related to 
the onset of EB, the Ogna mutant is of particular interest because it represents the 
only autosomal dominant mutation in plectin (Pfendner et al., 2005). As mentioned 
above, this mutation is a single amino acid change from arginine to tryptophan at 
position 2000 of the coiled-coil region of human plectin (Koss-Harnes et al., 2002) 
and position 1999 of mouse plectin.  
Using the coiled-coil prediction program COILS (Lupas et al., 1991), it is predicted 
that the arginine 1999 is at the position f of the heptad repeat (Figure 32) – on the 
surface of a coiled-coil dimer. While the overall heptad repeat positions for the 
individual amino acids do not change between wild-type and mutant, the position 
W1999 and its preceding amino acid Q1998 are predicted to shift from f to d and e to 
c, respectively. The replacement of a charged residue by the hydrophobic tryptophan 
may influence the coiled-coil stability in that region because of difficulties in packing 
the bulky aromatic tryptophan side chain into the coiled-coil interface.  
 
Figure 32 Schematic representation of the heptad repeat (a-g) of parallel and anti-parallel coiled-
coil dimers. Positions a and d of the coiled coil dimer are mostly hydrophobic residues - important for 
stabilising the coiled coil interaction, whereas positions e and g are often occupied by charged residues (Wagschal 
et al., 1999). Both parallel and anti-parallel dimer orientations are shown.  
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7.1 Recombinant wild-type plectin forms large assemblies 
Full-length plectin assembles into dimers via its coiled-coil domain (Wiche and 
Winter, 2011). Assemblies of different higher oligomeric structures have been 
observed, which was proposed to occur via the globular domains flanking the central 
rod of the protein (Wiche, 1989). Recombinant plectin-rod domain expressed in 
insect cells formed higher order structures in addition to dimers (Walko et al., 2011), 
suggesting that the coiled-coil domain is also able to form oligomers. A recent model 
proposed a lateral arrangement of plectin to be important for stabilising the 
hemidesmosomes (Walko et al., 2011).  
Despite the large size of the full-length recombinant coiled-coil domain, I was able to 
express it in E. coli (Figure 19e). Interestingly, I found the recombinant plectin rod 
expressed in bacteria to be largely in a monomeric state, aside from higher 
oligomers/aggregates. Additionally, the rod domain readily degraded to a size of 
50kDa. Nevertheless, it was observed that bacterial expressed wild-type plectin rod 
domain forms higher oligomers to a larger extent than Ogna does (Figure 22). The 
mutation is altering the oligomerisation behaviour of plectin. Thus, it might be 
possible that the mutation R1999W influences the protein’s ability to associate into 
larger structures. This was also discussed in a recent publication of Walko et al 
(Walko et al., 2011), where they observed different oligomerisation behaviour of the 
plectin/Ogna rod domain via electron microscopy studies. The diminished ability of 
Ogna to form this aggregates could be linked to the observed defects in EBS-Ogna 
(Walko et al., 2011). It has been reported for a dimeric coiled-coil protein (Bcr) that 
mutation of specific residues in the anti-parallel dimer are resulting in different 
oligomeric states of the protein (Taylor and Keating, 2005). 
 
7.2 The plectin rod domain is likely to be a parallel dimer 
To gain more insights into the influence of the R1999W mutation on the structural 
integrity of plectin, extensive crystallographic studies of fragments of the coiled-coil 
domain were conducted. The shortest construct – mini-rod - of the Ogna mutant was 
successfully crystallised and the structure showed an anti-parallel arrangement of the 
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coiled coil (Figure 24). Crystallisation of the wild-type counterpart plectin mini-rod 
was not successful. Although small needle clusters were observed, it was not possible 
to improve these crystals. The missing tryptophan 1999 that is involved in crystal 
contacts in the mutant plectin could be the reason. The loss of the stabilising 
interaction between neighbouring molecules might have influenced the 
crystallisation negatively. By means of EPR, I was able to show that both plectin and 
Ogna mini-rod have the same orientation, indicating that the mutation does not 
influence the orientation of the coiled-coil rod.  
Surprisingly, the coiled-coil orientation changed when the larger M-rod construct 
was studied by EPR (Figure 29, Figure 30). Although the chosen length of the small 
construct was expected to represent the whole coiled-coil region, this seemed to not 
be the case. It could be possible, that the anti-parallel orientation is more favourable 
for the short region from 1975-2081 (mini-rod), but not for the longer region from 
1808-2189 (M-rod). Rotary metal shadowing data of a construct containing four 
spectrin repeats in front of the coiled-coil domain showed the globular fragment only 
at one end of the coiled-coil dimer (Figure 31b). This, in combination with the 
observed inability of the N- and C- rod to interact, further supports a parallel 
arrangement of plectins coiled-coil domain.  
 
7.3 Recombinant plectin only partly dimerises 
An interesting finding during the diverse studies was the incomplete dimerisation 
stage of the recombinant protein. Both EPR and SLS studies revealed that plectin, 
regardless of wild-type or the mutant R1999W, is to some extent found in a 
monomeric state. The low modulation-depth observed by EPR measurements was the 
first indication of the incomplete dimerisation of plectin. The SLS-results of plectin 
mini-rod (wt/Ogna), M-rod (Ogna) and full-length (wt/Ogna), supported this finding 
(Figure 20). It is uncertain whether the bacterial expression system or the subsequent 
purification strategy contributes to the incomplete dimerisation. 
The absence of short distances in the mutants K1883C and E2149C of M-rod 
construct (wt/Ogna) also demonstrates that the termini of the mid-part of the coiled-
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coil rod are not in close vicinity, implying that this construct may only dimerise partly 
via its middle segment (Figure 33).  
 
Figure 33 Schematic representation of the EPR results for the M-rod. From the three different 
mutations tested by EPR, a model can be deduced. While the middle segment of plectin M-rod is a dimer, as 
indicated by mutation K2043C, both termini are not in the range of 2 nm, i.e. they are open at the ends. 
 
7.4 Difference between wild-type and R1999W plectin 
As mentioned in the introduction (part II, chapter 3), a current model of how the 
mutation of R1999!W influences the integrity of plectin states that a local 
destabilisation of the coiled-coil region due to the R1999W mutation makes the 
mutant plectin more susceptible to proteolytic degradation (Walko et al., 2011). 
During my experiments no differences in general degradation pattern were observed. 
If degradation occurred as for the full-length construct purified from bacteria, both 
plectin and Ogna seemed to be degraded to the same extent. Whether the putative 
degradation is connected with the different oligomerisation behaviour of the wild-
type and mutant plectin still awaits to be investigated. 
Wild-type and mutant plectin behaved similarly during the purification with the 
exception of their different oligomerisation capability. During the cross-linking 
studies I observed that wild-type plectin M- and mini-rod were cross-linked to a 
larger extent than the Ogna counterparts (Figure 20f). Whether this also reflects their 
dissimilar oligomerisation behaviour still needs to be investigated.  
Interestingly, during spin-labelling experiments it was noticed that Ogna is more 
difficult to label than its wild-type counterpart. All EPR-constructs of Ogna displayed 
lower label efficiency. In the case of Ogna mini-rod-K2043C, the spin label had to be 
N C
CN K2043C
K1883C E2149C
> 
2n
m
> 
2n
m
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increased from eight- to 20-fold in excess. If the mutation does in fact create a local 
disarrangement of the coiled coil, the neighbouring residues might be less accessible 
for the spin label. It is worth testing in the future the distances of the coiled coil in 
close proximity of the R1999W mutation in order to investigate potential disruptions 
of the coiled-coil stability.  
The data presented here relied on the assumption that the shorter coiled-coil 
segments behave similarly to the full-length rod. Due to the different results obtained 
for the diverse constructs, future studies should focus on the full-length rod. EPR 
studies of the full-length rod domain, purified from E. coli were not successful. This 
was due to both low yields and the degradation of the large construct. Studying the 
insect-cell expressed full-length construct by EPR was also not successful because the 
labelled protein readily aggregated during concentration and EPR measurements 
were not possible. Optimisation of buffers and purification strategies should be 
carried out to achieve higher concentration necessary for EPR and other biophysical 
studies.  
In conclusion, this study showed an influence on the oligomerisation state of plectin 
dependent on the mutation R1999W, but no differences on the ultrastructural level 
have been discovered so far. Characterisation of the potential influences on plectin’s 
function by the mutation R1999W will greatly promote the development of putative 
therapies for patients affected with EBS. 
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9 Appendix A: Bioinformatic tools & Databases 
BLAST   http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Coils    http://www.ch.embnet.org/software/COILS_form.html 
EMBOSS Transseq http://www.ebi.ac.uk/Tools/st/emboss_transeq/ 
MultAlin   http://multalin.toulouse.inra.fr/multalin/multalin.html 
PSIPRED v3.0  http://bioinf.cs.ucl.ac.uk/psipred/ 
ProtParam   http://web.expasy.org/protparam/ 
Protein data bank http://www.pdb.org/pdb/home/home.do 
PubMed   http://www.ncbi.nlm.nih.gov/pubmed/  
Sequence Editor   http://www.fr33.net/seqedit.php 
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